

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001826"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001826" />

    <meta name="citation_title" content="CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration"/>
    <meta itemprop="name" content="CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration"/>

      <meta name="citation_author" content="Ke Zen"/>
            <meta name="citation_author_institution" content="State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China"/>
            <meta name="citation_author_institution" content="Jiangsu CDC-Nanjing University Joint Institute of Virology, Nanjing, Jiangsu, China"/>
      <meta name="citation_author" content="Dan-Qing Liu"/>
            <meta name="citation_author_institution" content="State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China"/>
      <meta name="citation_author" content="Ya-Lan Guo"/>
            <meta name="citation_author_institution" content="State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China"/>
      <meta name="citation_author" content="Chen Wang"/>
            <meta name="citation_author_institution" content="State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China"/>
      <meta name="citation_author" content="Jun Shan"/>
            <meta name="citation_author_institution" content="State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China"/>
      <meta name="citation_author" content="Ming Fang"/>
            <meta name="citation_author_institution" content="Program of Cell and Molecular Biology, Department of Biology, Georgia State University, Atlanta, Georgia, United States of America"/>
      <meta name="citation_author" content="Chen-Yu Zhang"/>
            <meta name="citation_author_institution" content="State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China"/>
      <meta name="citation_author" content="Yuan Liu"/>
            <meta name="citation_author_institution" content="Program of Cell and Molecular Biology, Department of Biology, Georgia State University, Atlanta, Georgia, United States of America"/>

    <meta name="citation_date" content="2008/3/19"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001826.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1826"/>
    <meta name="citation_issue" content="3"/>
    <meta name="citation_volume" content="3"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion.; citation_author=T Nubel; citation_author=W Dippold; citation_author=H Kleinert; citation_author=B Kaina; citation_author=G Fritz; citation_journal_title=Faseb J; citation_volume=18; citation_number=1; citation_pages=140-142; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Regulation of the metastatic process by E-selectin and stress-activated protein kinase-2/p38.; citation_author=J Laferriere; citation_author=F Houle; citation_author=J Huot; citation_journal_title=Ann N Y Acad Sci; citation_volume=973; citation_number=2; citation_pages=562-572; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells.; citation_author=J Laferriere; citation_author=F Houle; citation_author=MM Taher; citation_author=K Valerie; citation_author=J Huot; citation_journal_title=J Biol Chem; citation_volume=276; citation_number=3; citation_pages=33762-33772; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=CD44 and its interaction with extracellular matrix.; citation_author=J Lesley; citation_author=R Hyman; citation_author=PW Kincade; citation_journal_title=Adv Immunol; citation_volume=54; citation_number=4; citation_pages=271-335; citation_date=1993; " />
      <meta name="citation_reference" content="citation_title=Positive correlation between sialyl Lewis X expression and pathologic findings in renal cell carcinoma.; citation_author=K Tozawa; citation_author=T Okamoto; citation_author=N Kawai; citation_author=Y Hashimoto; citation_author=Y Hayashi; citation_journal_title=Kidney Int; citation_volume=67; citation_number=5; citation_pages=1391-1396; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates.; citation_author=T Koike; citation_author=N Kimura; citation_author=K Miyazaki; citation_author=T Yabuta; citation_author=K Kumamoto; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=101; citation_number=6; citation_pages=8132-8137; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers.; citation_author=A Tozeren; citation_author=HK Kleinman; citation_author=DS Grant; citation_author=D Morales; citation_author=AM Mercurio; citation_journal_title=Int J Cancer; citation_volume=60; citation_number=7; citation_pages=426-431; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Role of metastatic potential in the adhesion of human breast cancer cells to endothelial monolayers.; citation_author=MA Moss; citation_author=S Zimmer; citation_author=KW Anderson; citation_journal_title=Anticancer Res; citation_volume=20; citation_number=8; citation_pages=1425-1433; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=P-selectin and PSGL-1: exploiting connections between inflammation and venous thrombosis.; citation_author=RP McEver; citation_journal_title=Thromb Haemost; citation_volume=87; citation_number=9; citation_pages=364-365; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells.; citation_author=CJ Dimitroff; citation_author=L Descheny; citation_author=N Trujillo; citation_author=R Kim; citation_author=V Nguyen; citation_journal_title=Cancer Res; citation_volume=65; citation_number=10; citation_pages=5750-5760; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.; citation_author=WD Hanley; citation_author=MM Burdick; citation_author=K Konstantopoulos; citation_author=R Sackstein; citation_journal_title=Cancer Res; citation_volume=65; citation_number=11; citation_pages=5812-5817; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands.; citation_author=SL Napier; citation_author=ZR Healy; citation_author=RL Schnaar; citation_author=K Konstantopoulos; citation_journal_title=J Biol Chem; citation_volume=282; citation_number=12; citation_pages=3433-3441; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions.; citation_author=J Bajorath; citation_journal_title=Proteins; citation_volume=39; citation_number=13; citation_pages=103-111; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Role of CD44 and hyaluronan in neutrophil recruitment.; citation_author=AI Khan; citation_author=SM Kerfoot; citation_author=B Heit; citation_author=L Liu; citation_author=G Andonegui; citation_journal_title=J Immunol; citation_volume=173; citation_number=14; citation_pages=7594-7601; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).; citation_author=HS Wang; citation_author=Y Hung; citation_author=CH Su; citation_author=ST Peng; citation_author=YJ Guo; citation_journal_title=Exp Cell Res; citation_volume=304; citation_number=15; citation_pages=116-126; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=CD44: structure, function, and association with the malignant process.; citation_author=D Naor; citation_author=RV Sionov; citation_author=D Ish-Shalom; citation_journal_title=Adv Cancer Res; citation_volume=71; citation_number=16; citation_pages=241-319; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9.; citation_author=P Spessotto; citation_author=FM Rossi; citation_author=M Degan; citation_author=R Di Francia; citation_author=R Perris; citation_journal_title=J Cell Biol; citation_volume=158; citation_number=17; citation_pages=1133-1144; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=CD44: the hyaluronan receptor.; citation_author=C Underhill; citation_journal_title=J Cell Sci; citation_volume=103 ( Pt 2); citation_number=18; citation_pages=293-298; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44.; citation_author=S Mine; citation_author=T Fujisaki; citation_author=C Kawahara; citation_author=T Tabata; citation_author=T Iida; citation_journal_title=Exp Cell Res; citation_volume=288; citation_number=19; citation_pages=189-197; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.; citation_author=Y Guo; citation_author=J Ma; citation_author=J Wang; citation_author=X Che; citation_author=J Narula; citation_journal_title=Cancer Res; citation_volume=54; citation_number=20; citation_pages=1561-1565; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.; citation_author=MA Zahalka; citation_author=E Okon; citation_author=U Gosslar; citation_author=B Holzmann; citation_author=D Naor; citation_journal_title=J Immunol; citation_volume=154; citation_number=21; citation_pages=5345-5355; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes.; citation_author=T Lechertier; citation_author=M Berard; citation_author=R Vassy; citation_author=MA Herve; citation_author=M Crepin; citation_journal_title=Anticancer Res; citation_volume=24; citation_number=22; citation_pages=4011-4017; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=A putative role for psoriasin in breast tumor progression.; citation_author=I Krop; citation_author=A Marz; citation_author=H Carlsson; citation_author=X Li; citation_author=N Bloushtain-Qimron; citation_journal_title=Cancer Res; citation_volume=65; citation_number=23; citation_pages=11326-11334; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.; citation_author=DD Edberg; citation_author=JN Adkins; citation_author=DL Springer; citation_author=R Reeves; citation_journal_title=J Biol Chem; citation_volume=280; citation_number=24; citation_pages=8961-8973; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.; citation_author=KB Bouker; citation_author=TC Skaar; citation_author=RB Riggins; citation_author=DS Harburger; citation_author=DR Fernandez; citation_journal_title=Carcinogenesis; citation_volume=26; citation_number=25; citation_pages=1527-1535; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding.; citation_author=G Tzircotis; citation_author=RF Thorne; citation_author=CM Isacke; citation_journal_title=J Cell Sci; citation_volume=118; citation_number=26; citation_pages=5119-5128; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Cancer. Proteases–invasion and more.; citation_author=DR Edwards; citation_author=G Murphy; citation_journal_title=Nature; citation_volume=394; citation_number=27; citation_pages=527-528; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Targeting the TGF beta signaling network in human neoplasia.; citation_author=N Dumont; citation_author=CL Arteaga; citation_journal_title=Cancer Cell; citation_volume=3; citation_number=28; citation_pages=531-536; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=A multigenic program mediating breast cancer metastasis to bone.; citation_author=Y Kang; citation_author=PM Siegel; citation_author=W Shu; citation_author=M Drobnjak; citation_author=SM Kakonen; citation_journal_title=Cancer Cell; citation_volume=3; citation_number=29; citation_pages=537-549; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases.; citation_author=PL Tremblay; citation_author=FA Auger; citation_author=J Huot; citation_journal_title=Oncogene; citation_volume=25; citation_number=30; citation_pages=6563-6573; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=The selectins and their ligands.; citation_author=SD Rosen; citation_author=CR Bertozzi; citation_journal_title=Curr Opin Cell Biol; citation_volume=6; citation_number=31; citation_pages=663-673; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Melanoma cell CD44 interaction with the alpha 1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation.; citation_author=JL Lauer-Fields; citation_author=NB Malkar; citation_author=G Richet; citation_author=K Drauz; citation_author=GB Fields; citation_journal_title=J Biol Chem; citation_volume=278; citation_number=32; citation_pages=14321-14330; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.; citation_author=S Jalkanen; citation_author=M Jalkanen; citation_journal_title=J Cell Biol; citation_volume=116; citation_number=33; citation_pages=817-825; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44.; citation_author=S Hibino; citation_author=M Shibuya; citation_author=MP Hoffman; citation_author=JA Engbring; citation_author=R Hossain; citation_journal_title=Cancer Res; citation_volume=65; citation_number=34; citation_pages=10494-10501; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=CD44 binds a chondroitin sulfate proteoglycan, aggrecan.; citation_author=T Fujimoto; citation_author=H Kawashima; citation_author=T Tanaka; citation_author=M Hirose; citation_author=N Toyama-Sorimachi; citation_journal_title=Int Immunol; citation_volume=13; citation_number=35; citation_pages=359-366; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=CD44 in cancer progression: adhesion, migration and growth regulation.; citation_author=R Marhaba; citation_author=M Zoller; citation_journal_title=J Mol Histol; citation_volume=35; citation_number=36; citation_pages=211-231; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.; citation_author=M Gotte; citation_author=GW Yip; citation_journal_title=Cancer Res; citation_volume=66; citation_number=37; citation_pages=10233-10237; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.; citation_author=LK Diaz; citation_author=X Zhou; citation_author=ET Wright; citation_author=M Cristofanilli; citation_author=T Smith; citation_journal_title=Clin Cancer Res; citation_volume=11; citation_number=38; citation_pages=3309-3314; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=The prognostic role of a gene signature from tumorigenic breast-cancer cells.; citation_author=R Liu; citation_author=X Wang; citation_author=GY Chen; citation_author=P Dalerba; citation_author=A Gurney; citation_journal_title=N Engl J Med; citation_volume=356; citation_number=39; citation_pages=217-226; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Prevention of tumor metastasis formation by anti-variant CD44.; citation_author=S Seiter; citation_author=R Arch; citation_author=S Reber; citation_author=D Komitowski; citation_author=M Hofmann; citation_journal_title=J Exp Med; citation_volume=177; citation_number=40; citation_pages=443-455; citation_date=1993; " />
      <meta name="citation_reference" content="citation_title=CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes.; citation_author=SB Wallach-Dayan; citation_author=V Grabovsky; citation_author=J Moll; citation_author=J Sleeman; citation_author=P Herrlich; citation_journal_title=J Cell Sci; citation_volume=114; citation_number=41; citation_pages=3463-3477; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness.; citation_author=A Herrera-Gayol; citation_author=S Jothy; citation_journal_title=Exp Mol Pathol; citation_volume=66; citation_number=42; citation_pages=99-108; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Actin microdomains on endothelial cells: association with CD44, ERM proteins, and signaling molecules during quiescence and wound healing.; citation_author=PV Jensen; citation_author=LI Larsson; citation_journal_title=Histochem Cell Biol; citation_volume=121; citation_number=43; citation_pages=361-369; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Directional sensing of a phorbol ester gradient requires CD44 and is regulated by CD44 phosphorylation.; citation_author=G Tzircotis; citation_author=RF Thorne; citation_author=CM Isacke; citation_journal_title=Oncogene; citation_volume=25; citation_number=44; citation_pages=7401-7410; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=CD44 cross-linking induces protein kinase C-regulated migration of human T lymphocytes.; citation_author=A Fanning; citation_author=Y Volkov; citation_author=M Freeley; citation_author=D Kelleher; citation_author=A Long; citation_journal_title=Int Immunol; citation_volume=17; citation_number=45; citation_pages=449-458; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins.; citation_author=T Fujisaki; citation_author=Y Tanaka; citation_author=K Fujii; citation_author=S Mine; citation_author=K Saito; citation_journal_title=Cancer Res; citation_volume=59; citation_number=46; citation_pages=4427-4434; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Endothelial leukocyte adhesion molecule 1: direct expression cloning and functional interactions.; citation_author=C Hession; citation_author=L Osborn; citation_author=D Goff; citation_author=G Chi-Rosso; citation_author=C Vassallo; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=87; citation_number=47; citation_pages=1673-1677; citation_date=1990; " />
      <meta name="citation_reference" content="citation_title=JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration.; citation_author=K Zen; citation_author=BA Babbin; citation_author=Y Liu; citation_author=JB Whelan; citation_author=A Nusrat; citation_journal_title=Mol Biol Cell; citation_volume=15; citation_number=48; citation_pages=3926-3937; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=CD11b/CD18-dependent interactions of neutrophils with intestinal epithelium are mediated by fucosylated proteoglycans.; citation_author=K Zen; citation_author=Y Liu; citation_author=D Cairo; citation_author=CA Parkos; citation_journal_title=J Immunol; citation_volume=169; citation_number=49; citation_pages=5270-5278; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro.; citation_author=EA Price; citation_author=DR Coombe; citation_author=JC Murray; citation_journal_title=Int J Cancer; citation_volume=65; citation_number=50; citation_pages=513-518; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration.; citation_author=JW Ryu; citation_author=KH Hong; citation_author=JH Maeng; citation_author=JB Kim; citation_author=J Ko; citation_journal_title=Arterioscler Thromb Vasc Biol; citation_volume=24; citation_number=51; citation_pages=864-870; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow.; citation_author=L Yang; citation_author=RM Froio; citation_author=TE Sciuto; citation_author=AM Dvorak; citation_author=R Alon; citation_journal_title=Blood; citation_volume=106; citation_number=52; citation_pages=584-592; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.; citation_author=A Roetger; citation_author=A Merschjann; citation_author=T Dittmar; citation_author=C Jackisch; citation_author=A Barnekow; citation_journal_title=Am J Pathol; citation_volume=153; citation_number=53; citation_pages=1797-1806; citation_date=1998; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001826" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration"/>
    <meta name="twitter:description" content="BackgroundEndothelial E-selectin has been shown to play a pivotal role in mediating cell&ndash;cell interactions between breast cancer cells and endothelial monolayers during tumor cell metastasis. However, the counterreceptor for E-selectin and its role in mediating breast cancer cell transendothelial migration remain unknown.Methodology/Principal FindingsBy assessing migration of various breast cancer cells across TNF-&alpha; pre-activated human umbilical vein endothelial cells (HUVECs), we found that breast cancer cells migrated across HUVEC monolayers differentially and that transmigration was E-selectin dependent. Cell surface labeling with the E-selectin extracellular domain/Fc chimera (exE-selectin/Fc) showed that the transmigration capacity of breast cancer cells was correlated to both the expression level and localization pattern of E-selectin binding protein(s) on the tumor cell surface. The exE-selectin/Fc strongly bound to metastatic MDA-MB-231, MDA-MB-435 and MDA-MB-468 cells, but not non-metastatic MCF-7 and T47D cells. Binding of exE-selectin/Fc was abolished by removal of tumor cell surface sialyl lewis x (sLex) moieties. Employing an exE-selectin/Fc affinity column, we further purified the counterreceptor of E-selectin from metastatic breast cancer cells. The N-terminal protein sequence and cDNA sequence identified this E-selectin ligand as a &sim;170 kD human CD44 variant 4 (CD44v4). Purified CD44v4 showed a high affinity for E-selectin via sLex moieties and, as expected, MDA-MB-231 cell adhesion to and migration across HUVEC monolayers were significantly reduced by down-regulation of tumor cell CD44v4 via CD44v4-specific siRNA.Conclusions/SignificanceWe demonstrated, for the first time, that breast cancer cell CD44v4 is a major E-selectin ligand in facilitating tumor cell migration across endothelial monolayers. This finding offers new insights into the molecular basis of E-selectin&ndash;dependent adhesive interactions that mediate breast cancer cell transendothelial metastasis."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001826.g006"/>

  <meta property="og:title" content="CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001826" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=2456'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=4109'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=4060&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001826">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001826" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001826&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Ke Zen
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">* E-mail:</span> <a href="mailto:kzen@nju.edu.cn">kzen@nju.edu.cn</a></p>

                <p>Affiliations:
                  State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China, 
                  Jiangsu CDC-Nanjing University Joint Institute of Virology, Nanjing, Jiangsu, China
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Dan-Qing Liu, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Ya-Lan Guo, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Chen Wang, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Jun Shan, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Ming Fang, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Program of Cell and Molecular Biology, Department of Biology, Georgia State University, Atlanta, Georgia, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Chen-Yu Zhang, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Yuan Liu
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Program of Cell and Molecular Biology, Department of Biology, Georgia State University, Atlanta, Georgia, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: March 19, 2008</li>
    <li>DOI: 10.1371/journal.pone.0001826</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001826" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001826" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001826" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001826" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001826-g001" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001826-g002" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001826-g003" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001826-g004" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001826-g005" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g005" title="Figure 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001826-g006" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g006" title="Figure 6">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g006&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001826">Reader Comments (2)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001826" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>Endothelial E-selectin has been shown to play a pivotal role in mediating cell–cell interactions between breast cancer cells and endothelial monolayers during tumor cell metastasis. However, the counterreceptor for E-selectin and its role in mediating breast cancer cell transendothelial migration remain unknown.</p>


<h3>Methodology/Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>By assessing migration of various breast cancer cells across TNF-α pre-activated human umbilical vein endothelial cells (HUVECs), we found that breast cancer cells migrated across HUVEC monolayers differentially and that transmigration was E-selectin dependent. Cell surface labeling with the E-selectin extracellular domain/Fc chimera (exE-selectin/Fc) showed that the transmigration capacity of breast cancer cells was correlated to both the expression level and localization pattern of E-selectin binding protein(s) on the tumor cell surface. The exE-selectin/Fc strongly bound to metastatic MDA-MB-231, MDA-MB-435 and MDA-MB-468 cells, but not non-metastatic MCF-7 and T47D cells. Binding of exE-selectin/Fc was abolished by removal of tumor cell surface sialyl lewis x (sLe<sup>x</sup>) moieties. Employing an exE-selectin/Fc affinity column, we further purified the counterreceptor of E-selectin from metastatic breast cancer cells. The N-terminal protein sequence and cDNA sequence identified this E-selectin ligand as a ~170 kD human CD44 variant 4 (CD44v4). Purified CD44v4 showed a high affinity for E-selectin via sLe<sup>x</sup> moieties and, as expected, MDA-MB-231 cell adhesion to and migration across HUVEC monolayers were significantly reduced by down-regulation of tumor cell CD44v4 via CD44v4-specific siRNA.</p>


<h3>Conclusions/Significance</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>We demonstrated, for the first time, that breast cancer cell CD44v4 is a major E-selectin ligand in facilitating tumor cell migration across endothelial monolayers. This finding offers new insights into the molecular basis of E-selectin–dependent adhesive interactions that mediate breast cancer cell transendothelial metastasis.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Zen K, Liu D-Q, Guo Y-L, Wang C, Shan J, et al.  (2008) CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration. PLoS ONE 3(3):
          e1826.
            doi:10.1371/journal.pone.0001826</p><p><strong>Academic Editor: </strong>Joseph P.R.O. Orgel, Illinois Institute of Technology, United States of America</p><p><strong>Received:</strong> December 7, 2007; <strong>Accepted:</strong> February 20, 2008; <strong>Published:</strong> March 19, 2008</p><p><strong>Copyright:</strong> © 2008 Zen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>First-aid grant from the American Heart Association (Yuan Liu), Research grant from Nanjing University (111 Project) (Ke Zen), China Basic Science 973 program (2006CB503909)(C.Y. Zhang, and K. Zen)</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Metastatic invasion is the primary cause of breast cancer mortality. A key step in the metastasis process is migration of tumor cells across the blood vessel-lining endothelial monolayers. It has been widely reported that endothelial cell E-selectin plays a pivotal role in mediating cell–cell interactions between tumor cells and endothelial monolayers during tumor metastasis <a href="#pone.0001826-Nubel1">[1]</a>, <a href="#pone.0001826-Laferriere1">[2]</a>, <a href="#pone.0001826-Laferriere2">[3]</a>. The major ligand of endothelial E-selectin on the tumor cell surface has been identified as a sialylated glycan determinant, such as sialyl Lewis x moieties (sLe<sup>x</sup>), which decorate the terminal extensions of O-linked or N-linked carbohydrates <a href="#pone.0001826-Lesley1">[4]</a>. Interaction of tumor cell surface sLe<sup>x</sup> moieties and sLe<sup>x</sup>-decorated glycoproteins with endothelium E-selectin is a major component of cancer invasion and metastasis. A positive correlation between expression of E-selectin ligands such as sLe<sup>x</sup> moieties in tumor cells and tumor cell metastasis or invasion has been widely reported <a href="#pone.0001826-Tozawa1">[5]</a>, <a href="#pone.0001826-Koike1">[6]</a>. In breast cancer cells, several studies have also demonstrated a critical role for E-selectin in regulating tumor cell transendothelial migration <a href="#pone.0001826-Tozeren1">[7]</a>, <a href="#pone.0001826-Moss1">[8]</a>. However, the identity of the E-selectin ligand in breast cancer cells and its physiological contribution in regulating tumor cell transendothelial migration is unknown.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Several leukocyte adhesion molecules, including leukocyte P-selectin glycoprotein ligand-1 (PSGL-1) and E-selectin ligand-1 (ESL-1), have been identified as ligands for endothelial E-selectin <a href="#pone.0001826-McEver1">[9]</a>. These interactions between PSGL-1, ESL-1 and E-selectin play a significant role in regulating leukocyte rolling process. Dimitroff et al. <a href="#pone.0001826-Dimitroff1">[10]</a> reported that both E-selectin binding forms of PSGL-1 and ESL-1 are expressed on the human bone-metastatic prostate tumor MDA PCa 2b cell line, suggesting that these molecules may serve as E-selectin ligands in mediating tumor cell adhesion to or migration across endothelium. However, it is unclear whether breast cancer cells or other non-bone derived metastatic tumor cells express PSGL-1 or ESL-1. Recently, studies have demonstrated that CD44 variant isoforms (CD44v) in LS174T colon carcinoma cells possess selectin binding activity <a href="#pone.0001826-Hanley1">[11]</a>, <a href="#pone.0001826-Napier1">[12]</a>, suggesting a broader role for CD44v in regulating tumor cell metastasis, particularly the event of migration across the vascular endothelium. CD44 was originally identified as a leukocyte homing receptor, and its globular amino-terminal domain contains hyaluronic acid (HA)–binding motifs and several potential glycosylation sites <a href="#pone.0001826-Bajorath1">[13]</a>. Through its interaction with hyaluronan, CD44 serves as an adhesion molecule in cell–substrate and cell–cell interactions, lymphocyte recruitment to inflammatory sites, and tumor metastasis <a href="#pone.0001826-Khan1">[14]</a>, <a href="#pone.0001826-Wang1">[15]</a>, <a href="#pone.0001826-Naor1">[16]</a>, <a href="#pone.0001826-Spessotto1">[17]</a>. The size of the CD44 molecule ranges from the standard 85–95 kD form (CD44s) to larger variant isoforms of 200 kD or more due to RNA splicing and post-translational modifications <a href="#pone.0001826-Underhill1">[18]</a>. Functional characterization of different isoforms of the CD44 family, however, is still limited. Many cancer cell types express high levels of specific variants of CD44 <a href="#pone.0001826-Mine1">[19]</a>. The animal model studies have shown that interfering with the binding of CD44 to its ligand inhibits local tumor growth and metastatic spread <a href="#pone.0001826-Guo1">[20]</a>, <a href="#pone.0001826-Zahalka1">[21]</a>. During tumor metastasis, cells detach from the primary tumor, penetrate the basement membrane into the connective tissue, and invade adjacent organs structures, including blood vessels. Tumor cells are subsequently transported to metastatic sites through the blood stream. However, the mechanisms by which CD44 modulates the tumor cell transendothelial migration process are not fully understood.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>In the present study, we demonstrated that metastatic breast cancer cells strongly express a ~170 kD CD44 variant 4 (CD44v4). The expression level and localization pattern of CD44v4 in breast cancer cells is closely correlated with tumor cell migratory capability across TNF-α pre-activated HUVEC monolayers. Our results further showed that CD44v4 is highly decorated with E-selectin binding sLe<sup>x</sup> moieties and serves as a major adhesive molecule in mediating breast cancer cell transendothelial metastasis.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Results"></a><h3>Results</h3>
<h4>Breast cancer cell transendothelial migration is E-selectin dependent</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>HUVEC monolayers cultured on collagen-coated permeable Transwell filters were used as a model for endothelial cell monolayers to assess the transmigration of breast cancer cells. HUVEC monolayers were pre-activated with 25 ng/ml TNF-α for 6 h to upregulate the expression of adhesion molecules before the tumor migration assay. Five breast cancer cell lines including MDA-MB-231, MDA-MB-435, MDA-MB-468, T47D, and MCF-7 were assessed for their migratory capability across HUVEC monolayers. The general migratory capability of these five breast cancer cells has been well-studied <a href="#pone.0001826-Wang1">[15]</a>, <a href="#pone.0001826-Lechertier1">[22]</a>–<a href="#pone.0001826-Bouker1">[25]</a>. Various breast cancer cells have a marked differential migratory capability. Among five cancer cell lines, MDA-MB-231, MDA-MB-435 and MDA-MB-468 have a higher invasive ability and are generally regarded as metastatic breast cancer cells while MCF-7 and T47D cells have a lower invasive ability and are regarded as non-metastatic cells. As shown in <a href="#pone-0001826-g001">Figure 1A</a>, MDA-MB-231 had the highest transmigration rate across TNF-α pre-activated HUVEC <span class="underline">monolayers</span> while MDA-MB-435 and MDA-MB-468 cells demonstrated relatively modest transmigration. Compared to these metastatic breast cancer cells, MCF-7 cells and T47D cells had a significantly lower transmigration rate. The transmigration of MDA-MB-231, MDA-MB-435 and MDA-MB-468 cross TNF-α pre-activated HUVEC monolayers was further characterized in the presence of various functional inhibitory antibodies. As shown in <a href="#pone-0001826-g001">Fig. 1B</a>, migration of MDA-MB-231 cells cross HUVEC monolayers was significantly blocked by anti-E-selectin antibody, but not by inhibitory antibodies against LFA-1 or VLA-4 (<a href="#pone-0001826-g001">Fig. 1B</a>), suggesting that metastasis of breast cancer cells across TNF-α pre-activated HUVEC monolayers is specifically dependent on HUVEC E-selectin. Similar inhibition by anti-E-selectin antibody on tumor cell transendothelial migration was observed in both MDA-MB-435 and MDA-MB-468 cell migration assays (data not shown).</p>
<div class="figure" id="pone-0001826-g001"><div class="img"><a name="pone-0001826-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Transendothelial migration of breast cancer cells.</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p>A: differential migration of breast cancer cells across HUVEC monolayers pre-activated with TNF-α. B: migration of MDA-MB-231 across HUVEC monolayers in the presence of anti-E-selectin, anti-ICAM-1, and anti-VLA-4 antibodies (25 µg/ml each), respectively. HUVEC monolayers were pre-incubated with endothelial medium containing 25 ng/ml TNF-α for 6 h, and migration was terminated after overnight incubation at 37°C. All data are expressed as the mean±SD (<em>n</em> = 3) of a typical experiment and similar results were obtained in at least three separate experiments.</p>
<span>doi:10.1371/journal.pone.0001826.g001</span></div><a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>Since the migration results suggest that E-selectin plays a critical role in mediating breast cancer cell transendothelial migration, we next examined the interactions of breast cancer cells with a soluble recombinant protein of E-selectin extracellular domain (exE-selectin/Fc). A direct binding assay of breast cancer cells with soluble exE-selectin/Fc was performed. In the experiment, exE-selectin/Fc or Fc-only (served as a control) was incubated with non-fixed breast cancer cells at 4°C for 1 h, and bound Fc was detected by fluorescently conjugated goat anti-rabbit Fc antibody. As shown in <a href="#pone-0001826-g002">Figure 2</a>, the exE-selectin/Fc recombinant strongly bound to MDA-MB-231, MDA-MB-435 and MDA-MB-468 cell surfaces. The Fc-only control did not bind to any breast cancer cells. In contrast to MDA-MB-231, MDA-MB-435 and MDA-MB-468 cells, MCF-7 cells showed no significant binding of exE-selectin/Fc recombinant. A similar negative staining of exE-selectin/Fc was observed in T47D cells (data not shown). Since sLe<sup>x</sup> moieties are major binding partners of E-selectin, we further determined whether the binding of exE-selectin/Fc to metastatic breast cancer cells was dependant on tumor cell surface sLe<sup>x</sup> moieties. As shown in the figure, removal of sLe<sup>x</sup> moieties from the tumor cell surface by neuraminidase treatment markedly reduced the binding of exE-selectin/Fc. Taken together, these results suggested that sLe<sup>x</sup> moieties are likely involved in mediating the binding interactions of breast cancer cells to E-selectin and that breast cancer cell transendothelial migration is positively correlated to the binding activity of the exE-selectin/Fc recombinant to tumor cells.</p>
<div class="figure" id="pone-0001826-g002"><div class="img"><a name="pone-0001826-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Binding of soluble exE-selectin/Fc recombinant to breast cancer cells via sLe<sup>x</sup> moieties on the tumor cell surface.</span></strong></p><a id="article1.body1.sec2.sec1.fig2.caption1.p1" name="article1.body1.sec2.sec1.fig2.caption1.p1"></a><p>Trypsin-elicited breast cancer cells were surface labeled with soluble exE-selectin/Fc or Fc-only as detailed in the <a href="#s4">Methods</a>. The bound Fc recombinants were detected by Alexa Fluor 488-conjugated goat anti-rabbit Fc and measured by FACS. In separated experiments, tumor cells were treated with neuraminidase to remove surface sLe<sup>x</sup> moieties before exE-selectin/Fc binding.</p>
<span>doi:10.1371/journal.pone.0001826.g002</span></div><a id="article1.body1.sec2.sec1.p3" name="article1.body1.sec2.sec1.p3"></a><p>We next determined the localization pattern of E-selectin binding protein(s) on the breast cancer cell surface. Tumor cells cultured in tissue culture dishes were directly incubated with soluble exE-selectin/Fc or Fc-only for 1 h at 4°C. As shown in <a href="#pone-0001826-g003">Figure 3</a>, MDA-MB-231, MDA-MB-435 and MDA-MB-468 cells were all strongly labeled with exE-selectin/Fc, while MCF-7 and T47D were not or only weakly stained. This observation was in agreement with flow cytometry analysis (<a href="#pone-0001826-g002">Fig. 2</a>). However, among three metastatic breast cancer cells, the binding patterns of the exE-selectin/Fc recombinant were strikingly different. On the surface of highly metastatic MDA-MB-231 cells, exE-selectin/Fc bound strongly to the migrating front of the cell (arrows), particularly the “spiking” cellular protrusions (arrowheads). In contrast, exE-selectin/Fc was found to be concentrated at sites of cell-cell contact in both MDA-MB-435 and MDA-MB-468 cells, which had relatively less transmigration compared to MDA-MB-231 cells (<a href="#pone-0001826-g001">Fig. 1</a>). These results suggested that metastatic breast cancer cell transendothelial migration might also be correlated to the localization pattern of E-selectin binding protein(s) on the tumor cell surface. Co-staining MDA-MB-231 cells with exE-selectin/Fc recombinant and rhodamine-conjugated phalloidin showed that F-actin (red, arrows) was predominantly localized at the exE-selectin/Fc binding region (green, arrows), including the “spiking” cellular protrusions (arrowheads). The co-distribution of F-actin and the exE-selectin/Fc recombinant in metastatic breast cancer cells suggests that the E-selectin binding protein(s) were mainly localized to the leading edge or migrating front of MDA-MB-231 cells during metastasis.</p>
<div class="figure" id="pone-0001826-g003"><div class="img"><a name="pone-0001826-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>Localization of potential E-selectin ligand(s) on the breast cancer cell surface.</span></strong></p><a id="article1.body1.sec2.sec1.fig3.caption1.p1" name="article1.body1.sec2.sec1.fig3.caption1.p1"></a><p>A: After blocking with 5% normal goat serum in PBS, breast cancer cells cultured in a tissue culture dish were incubated with exE-selectin/Fc (10 µg/ml) in blocking solution for 1 h at 4°C. Following three washes, cells were fixed with 3.5% paraformaldehyde (5 min, 20°C) and the bound exE-selectin/Fc was detected by Alexa Fluor 488-conjugated anti-rabbit Fc. Cell surface labeling with Fc-only served as a background control. B: To determine the localization of E-selectin ligand on metastatic tumor cell surfaces during migration, MDA-MB-231 cells were double labeled with soluble exE-selectin/Fc for E-selectin ligand (left panel) and rhodamine-conjugated phalloidin for F-actin (right panel). Bar, 20 µm.</p>
<span>doi:10.1371/journal.pone.0001826.g003</span></div>

<h4>Identification of breast cancer cell CD44v4 as a major sLe<sup>x</sup> moieties-decorated membrane glycoprotein that binds to E-selectin</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>In order to isolate and identify the E-selectin binding protein(s) that mediate breast cancer cell adhesion to and migration across endothelial monolayers, we constructed an affinity column by immobilizing exE-selectin/Fc to protein A-conjugated Sepharose. ~5×10<sup>8</sup> MDA-MB-231 cells were used to obtain sufficient quantities of E-selectin ligand for microsequence analysis. As shown in <a href="#pone-0001826-g004">Figure 4A</a>, three major bands around 170 kD, 130 kD and 50 kD were found in the eluted proteins. Among these three protein bands, the 50 kD and 130 kD bands were confirmed as IgG heavy chain and the exE-selectin/Fc recombinant, respectively. Thus, the protein band at 170 kD was selected for further analysis. The N-terminal peptide sequence of 10 amino acids, QIDLNITCRFA, from the 170 kD purified protein had a sequence that 100% matched the matured form of human CD44, a highly glycosylated membrane protein (<a href="#pone-0001826-g004">Fig. 4B</a>). The CD44 identity of this glycoprotein was further confirmed by Western blot analysis against anti-CD44H antibody, which can recognize all CD44 variants (<a href="#pone-0001826-g004">Fig. 4C</a>). Western blot results also confirmed that metastatic MDA-MB-231, MDA-MB-435 and MDA-MB-468 cells all strongly expressed CD44, while non-metastatic MCF-7 and T47D cells had little CD44 expression.</p>
<div class="figure" id="pone-0001826-g004"><div class="img"><a name="pone-0001826-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>Identification of the major E-selectin binding protein in metastatic breast cancer cells as human CD44.</span></strong></p><a id="article1.body1.sec2.sec2.fig1.caption1.p1" name="article1.body1.sec2.sec2.fig1.caption1.p1"></a><p>A: Gel-code staining of proteins eluted from an exE-selectin/Fc affinity column. A 170 kD protein indicated by the arrow was selected as a potential ligand of E-selectin in tumor cells since 130 kD and 50 kD protein bands were confirmed as exE-selectin/Fc and IgG heavy chain, respectively. B: matching of the 10 amino acid N-terminal peptide sequence (red) of the 170 kD purified protein with that of human CD44. C: Western blot analysis of five breast cancer cell lines with anti-CD44H antibody.</p>
<span>doi:10.1371/journal.pone.0001826.g004</span></div><a id="article1.body1.sec2.sec2.p2" name="article1.body1.sec2.sec2.p2"></a><p>Since CD44 has multiple variants containing the common N- and C-terminal region but a different inserted portion within the extracellular domain due to alternative splicing, the N-terminal sequence alone can not distinguish which CD44 variant is involved in mediating breast cancer transendothelial metastasis. To solve this problem, we amplified the cDNA encoding the CD44 extracellular domain from various breast cancer cells using a pair of primers, forward primer <span class="gene">5′-TATAAGCTTTTCGCTCCGGACACCATGGACAAG-3′</span>, and reverse primer <span class="gene">5′-ATAAGATCT TTCTGGAATTTGGGGTGTCCTTAT-3′</span>. Since this pair of primers target the sequence shared by all CD44 variants, they amplify all variant isoforms of the CD44 protein. As shown in <a href="#pone-0001826-g005">Figure 5A</a>, a major band around 1.2 kb was observed in MDA-MB-231, MDA-MB-435 and MDA-MB-468. The DNA sequence of the 1.2 kb PCR product indicated that it was CD44 variant 4 (CD44v4) (gene accession number: NM001001391). No PCR product was amplified from either MCF-7 or T47D cells. Interestingly, a slightly larger PCR product was amplified from colonic HT29 cells using the same primers, and its sequence matched that of CD44 variant 3 (CD44v3) (gene accession number: NM001001390). To confirm CD44v4 identification by PCR, we blotted the 170 kD purified protein with a panel of monoclonal antibodies that specifically react with different variants of human CD44. As shown in <a href="#pone-0001826-g005">Figure 5B</a>, Western blot analysis confirmed the 170 kD protein as CD44v4 (<a href="#pone-0001826-g005">Fig. 5B</a>). Blotting the 170 kD protein band with anti-sLe<sup>x</sup> moieties antibody also showed that this CD44 variant isoform was decorated with sLe<sup>x</sup> moieties. <a href="#pone-0001826-g005">Figure 5C</a> shows the specific binding of purified CD44v4 to exE-selectin/Fc and that this binding occurred through sLe<sup>x</sup> moieties on CD44v4.</p>
<div class="figure" id="pone-0001826-g005"><div class="img"><a name="pone-0001826-g005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g005.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 5.  <span>Identification of the CD44 variant isoform in metastatic breast cancer cells as CD44v4.</span></strong></p><a id="article1.body1.sec2.sec2.fig2.caption1.p1" name="article1.body1.sec2.sec2.fig2.caption1.p1"></a><p>A: RT-PCR amplification and DNA sequence of CD44 extracellular domain from various breast cancer cells and colonic HT29 cells. B: Western blot analysis of the 170 kD purified protein with antibodies specific to sLe<sup>x</sup> moieties and different CD44 variant isoforms, respectively. C: Specific binding of the 170 kD purified protein (CD44v4) to E-selectin through sLe<sup>x</sup> moieties. The data are represented as the mean±SD of three different experiments.</p>
<span>doi:10.1371/journal.pone.0001826.g005</span></div>

<h4>CD44v4 serves as a major E-selectin ligand in mediating breast cancer cell transendothelial metastasis</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>To characterize the role of CD44v4 in mediating breast cancer cell transendothelial migration, we next examined the effects of CD44v4 knockdown as well as removal of tumor cell surface sLe<sup>x</sup> moieties on tumor cell adhesion to and migration across TNF-α pre-activated HUVEC monolayers. CD44v4 knockdown in breast cancer cells was achieved by transfecting MDA-MB-231 cells with CD44v4 siRNA <a href="#pone.0001826-Tzircotis1">[26]</a>. As shown in <a href="#pone-0001826-g006">Figure 6A</a>, Western blot analysis demonstrated that the CD44v4 expression level was significantly decreased in MDA-MB-231 cells after CD44v4 siRNA transfection. However, CD44v4 protein level was not changed in MDA-MB-231 cells transfected with control oligonucleotides. A marked decrease in cell surface expression of CD44v4 after CD44v4 siRNA transfection was also shown by cell surface immunofluorescence labeling (<a href="#pone-0001826-g006">Fig. 6B</a>). Interestingly, CD44v4 siRNA transfection not only decreased the CD44v4 protein level on the MDA-MB-231 cell surface, but also changed tumor cell morphology. As can be seen in <a href="#pone-0001826-g006">figure 6B</a>, mock–transfected MDA-MB-231 cells maintained their typical spindle shape and had numerous “spiking” protrusions brightly labeled with anti-CD44H antibody (arrowheads). In contrast, in CD44v4 siRNA–transfected MDA-MB-231 cells, no anti-CD44H antibody labeled “spiking” cellular protrusions were observed, and tumor cells had lost their long spindle shape. The E-selectin binding and transmigration capacity of MDA-MB-231 cells before and after CD44v4 downregulation was further determined. As shown in <a href="#pone-0001826-g006">Figure 6C</a>, mock-transfected MDA-MB-231 cells strongly adhered to immobilized exE-selectin/Fc, with an adhesion rate of 79.5±10.2% of the total applied cells. However, the adhesion of CD44v4 siRNA-transfected MDA-MB-231 cells was significantly decreased, with an adhesion rate of 31.2±7.4%. The adhesion rate of CD44v4-downregulated MDA-MB-231 cells was close to that of MDA-MB-231 cells pretreated with neuraminidase (21.4±4.2%). Similar results were observed in adhesion assays using TNF-α pre-activated HUVEC monolayers instead of immobilized recombinant exE-selectin/Fc (<a href="#pone-0001826-g006">Fig. 6D</a>). CD44v4 siRNA–transfected MDA-MB-231 cells also showed a marked reduction in transmigration across TNF-α pre-activated HUVEC monolayers. As shown in <a href="#pone-0001826-g006">Figure 6E</a>, after overnight incubation, transendothelial migration of MDA-MB-231 cells transfected with CD44v4 siRNA was reduced to only one third of that of mock-transfected MDA-MB-231 cells.</p>
<div class="figure" id="pone-0001826-g006"><div class="img"><a name="pone-0001826-g006" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g006&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001826" data-uri="info:doi/10.1371/journal.pone.0001826.g006"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001826.g006&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g006/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g006/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g006/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g006/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g006.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001826.g006/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001826.g006/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001826.g006.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 6.  <span>The role of CD44v4 in mediating breast cancer cell adhesion and transmigration.</span></strong></p><a id="article1.body1.sec2.sec3.fig1.caption1.p1" name="article1.body1.sec2.sec3.fig1.caption1.p1"></a><p>A and B: siRNA transfection-induced CD44v4 downregulation in MDA-MB-231 cells as shown by Western blot (A) and immunofluorescence labeling (B), respectively. C and D: reduction of MDA-MB-231 cell adhesion to immobilized recombinant exE-selectin/Fc (C) and TNF-α pre-activated HUVEC monolayers (D) after CD44v4 downregulation via siRNA. E: reduction of MDA-MB-231 cell transendothelial migration by CD44v4 downregulation. The data are representative of three independent experiments.</p>
<span>doi:10.1371/journal.pone.0001826.g006</span></div>
</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>Breast carcinoma is one of the most common tumors recently found in female patients, and its metastasis is a major cause of death. Although the metastasis of breast cancer cells is a complex process that requires the activity of multiple genes including urokinase plasminogen activator, cytokines, chemokines, and matrix metalloproteinases (MMPs) <a href="#pone.0001826-Edwards1">[27]</a>, <a href="#pone.0001826-Dumont1">[28]</a>, <a href="#pone.0001826-Kang1">[29]</a>, it has been widely reported that the selectin family of adhesion molecules and their ligands play a critical role in tumor cell metastasis through blood vessels <a href="#pone.0001826-Nubel1">[1]</a>, <a href="#pone.0001826-Laferriere1">[2]</a>, <a href="#pone.0001826-Laferriere2">[3]</a>. During tumor cell metastasis, binding interactions generally occurred between selectin-expressed endothelial cell monolayers and selectin ligands on tumor cells. The binding capacity of tumor cells to blood vessel-lining endothelium through E-selectin was closely correlated to the metastatic capability of breast cancer cells. A previous study demonstrated that E-selectin ligation regulated the transendothelial migration of colon cancer cells via mediating p38 and ERK MAP kinase activation <a href="#pone.0001826-Tremblay1">[30]</a>. However, E-selectin ligands expressed in migrating tumor cells, particularly breast cancer cells, are not well-characterized. In the present study, we show that the CD44 variant isoform 4 (CD44v4) is a major metastatic breast cancer cell glycoprotein decorated with sLe<sup>x</sup> moieties and serves as an E-selectin ligand in facilitating tumor cell migration across TNF-α pre-activated HUVEC monolayers.</p>

<h4>CD44v4 mediates breast cancer cell adhesion to endothelial monolayers via interacting with E-selectin</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>In the present study, the binding activity of breast cancer cells to E-selectin was carefully characterized at the cellular level. Using soluble E-selectin/Fc recombinant as a probe, we directly detected the binding of E-selectin to living breast cancer cells. The results clearly demonstrated a positive correlation between the binding activity of soluble E-selectin/Fc recombinant and the ability of breast cancer cells to migrate across endothelial cell monolayers. Firstly, E-selectin binding protein(s) are abundantly expressed in metastatic breast tumor cells including MDA-MB-231, MDA-MB-435 and MDA-MB-468, but not in non-metastatic tumor cells such as MCF-7 and T47D (<a href="#pone-0001826-g002">Fig. 2</a> and <a href="#pone-0001826-g003">Fig. 3</a>). Secondly, labeling of E-selectin/Fc recombinant on the breast cancer cell surface also demonstrated a strikingly different pattern among various metastatic tumor cells. As shown in <a href="#pone-0001826-g003">Figure 3</a>, in MDA-MB-231 cells, which had the highest transmigration rate across TNF-α pre-activated HUVECs, the E-selectin/Fc recombinant strongly bound to the migrating cell front, particularly the “spiking” structures of cell protrusions. In contrast, in MDA-MB-435 and MDA-MB-468 cells, which had relative lower transmigration rates compared to MDA-MB-231 cells, binding of the E-selectin/Fc recombinant was mainly found at sites of cell-cell contacts. Taken together, these results suggest that breast cancer cell transendothelial migration is closely correlated to both the expression level and localization pattern of cell surface E-selectin binding protein(s). In the present study, we selected HUVEC as a model endothelial cell line to characterize the interactions between breast cancer cells and endothelial monolayers during tumor metastasis is mainly due to the simplicity of HUVEC system. However, for better understanding breast tumor cell migration across blood vessel-lining endothelium under pathophysiologic conditions, primary cultured endothelial cells that are isolated from particular blood vessels should be used. Moreover, in order to mimic the real physiological situation of tumor metastasis, tumor cell transmigration across HUVEC monolayers pre-activated by TNF-α should be also measured under flow condition.</p>
<a id="article1.body1.sec3.sec1.p2" name="article1.body1.sec3.sec1.p2"></a><p>The binding of the E-selectin/Fc recombinant to metastatic breast cancer cells was largely reduced by removal of sLe<sup>x</sup> moieties from tumor cell surfaces (<a href="#pone-0001826-g002">Fig. 2</a> and <a href="#pone-0001826-g006">Fig. 6C</a>), suggesting that the E-selectin binding protein(s) in metastatic breast cancer cells are decorated with sLe<sup>x</sup> moieties and that sLe<sup>x</sup> moieties play a significant role in mediating tumor cell binding to E-selectin. Considering that sLe<sup>x</sup> moieties are major E-selectin binding partner <a href="#pone.0001826-Rosen1">[31]</a>, this finding was not surprising. It is well-known that sLe<sup>x</sup> moieties can mediate adhesion of tumor cells to the endothelium via interactions with E-selectin. In normal breast tissues, the expression levels of sLe<sup>x</sup> moieties and sLe<sup>x</sup> moiety-decorated glycoproteins are very low. However, up-regulation of sLe<sup>x</sup> moiety expression has been widely reported to be correlated with poor prognosis and malignant relapse <a href="#pone.0001826-Tozawa1">[5]</a>, <a href="#pone.0001826-Koike1">[6]</a>.</p>
<a id="article1.body1.sec3.sec1.p3" name="article1.body1.sec3.sec1.p3"></a><p>By using an affinity column constructed by immobilizing E-selectin/Fc recombinant, the E-selectin binding protein that mediated breast cancer cell transendothelial migration was identified as human CD44 (<a href="#pone-0001826-g004">Fig. 4</a>). Further analysis based on RT-PCR and Western blot indicated it as CD44 variant 4 (CD44v4) (<a href="#pone-0001826-g005">Fig. 5</a>). As a multistructural and multifunctional cells surface adhesion molecule, CD44 is involved in cell-cell and cell-matrix interactions <a href="#pone.0001826-Bajorath1">[13]</a>, <a href="#pone.0001826-Naor1">[16]</a>. There are multiple ligands of CD44, including the extracellular matrix (ECM) components collagen <a href="#pone.0001826-LauerFields1">[32]</a>, fibronectin <a href="#pone.0001826-Jalkanen1">[33]</a>, laminin <a href="#pone.0001826-Hibino1">[34]</a>, chondroitin sulfate <a href="#pone.0001826-Fujimoto1">[35]</a> and, particularly, hyaluronic acid (HA) <a href="#pone.0001826-Underhill1">[18]</a>. Through binding all of these ligands, CD44 plays a critical role in initiating the metastatic spread of tumor cells <a href="#pone.0001826-Naor1">[16]</a>, <a href="#pone.0001826-Marhaba1">[36]</a>, <a href="#pone.0001826-Gotte1">[37]</a>. Structurally, the genomic organization of CD44 is composed of twenty exons. Besides the first five and last five constant exons, there are 10 exons located between these regions that are subjected to alternative splicing, resulting in the generation of a variable region. Differential utilization of the 10 variable region exons, as well as variations in N- or O-glycosylation and glycosaminoglycanation (heparan sulfate or chondroitin sulfate), generates multiple CD44 isoforms. These isoforms have various tissue specificity and ligand binding activity. Some CD44 isoforms have been found to play an essential role in tumor progression <a href="#pone.0001826-Diaz1">[38]</a>. Here, for the first time, our results demonstrate that CD44v4 is a major CD44 isoform expressed in metastatic breast cancer cells, and this CD44 variant is a membrane glycoprotein decorated with E-selectin binding sLe<sup>x</sup> moieties.</p>


<h4>CD44v4 mediates breast cancer migration across endothelial cell monolayers</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>High levels of various CD44 variants (CD44v) are widely found in metastatic breast carcinoma <a href="#pone.0001826-Mine1">[19]</a>, <a href="#pone.0001826-Diaz1">[38]</a>, <a href="#pone.0001826-Liu1">[39]</a>. This is confirmed by our observation that three metastatic breast carcinoma cell lines, MDA-MB-231, MDA-MB-435 and MDA-MB-468, expressed high levels of CD44v4 (<a href="#pone-0001826-g004">Fig. 4</a> and <a href="#pone-0001826-g005">5</a>). A number of lines of evidences have implicated CD44v with a possible role in tumor progression <a href="#pone.0001826-Seiter1">[40]</a>, <a href="#pone.0001826-WallachDayan1">[41]</a>. However, how each CD44v contributes to the malignant phenotype, particularly the transmigration event of breast cancer cells across the endothelial monolayers lining the blood vessels, is largely unknown. Herrera-Gayol and Jothy <a href="#pone.0001826-HerreraGayol1">[42]</a> showed that CD44 variants (especially CD44v6) could regulate the binding of breast cancer cells to extracellular HA, and these binding interactions could mediate tumor cell metastasis. Recently, Napier et al <a href="#pone.0001826-Napier1">[12]</a> demonstrated that the LS174 colon carcinoma cell CD44 variant bound to selectin through sialidase-sensitive O-linked glycans presented on CD44. Here, we present evidence that CD44v4 is a major E-selectin ligand expressed in metastatic breast cancer cells, and plays a critical role in regulating tumor cell transendothelial invasion. In addition, binding of the E-selectin/Fc recombinant to the migrating front and particularly the “spiking” protrusions of MDA-MB-231 cells (<a href="#pone-0001826-g003">Fig. 3</a>) suggest that CD44v4 may be a key component of the tumor cell migration machinery. CD44v4 is likely involved in reorganization of the cell cytoskeleton during cell directional movement since CD44 variants can strongly associate with actin microdomains and ERM proteins <a href="#pone.0001826-Jensen1">[43]</a>. CD44v4 may also regulate breast cancer cell transendothelial metastasis by functioning not only as an adhesive receptor for E-selectin, but also as a signaling transducer. It has been reported that phosphorylation of the CD44 isoform is required in tumor cell directional sensing of a phorbol ester gradient during invasion <a href="#pone.0001826-Tzircotis2">[44]</a>. Engagement of CD44 has also been shown to induce protein kinase C and Rac activation during cell migration <a href="#pone.0001826-Fanning1">[45]</a>. By pretreating breast cancer cells with a cross-linking reagent such as anti-CD44 antibody, Wang et al <a href="#pone.0001826-Wang1">[15]</a> reported that ligation of tumor cell surface CD44 enhanced tumor cell transendothelial migration by increasing the expression of lymphocyte function-associated antigen-1 (LFA-1) and very late antigen 4 (VLA-4). Similar up-regulation of tumor cell integrins and integrin-mediated adhesion by CD44 ligation was also found in a colon cancer cell line <a href="#pone.0001826-Fujisaki1">[46]</a>. One possible mechanism by which CD44 ligation enhances integrin expression and tumor cell adhesion is through up-regulation of c-Met <a href="#pone.0001826-Fujisaki1">[46]</a>. In the present study, however, we did not find a significant inhibitory role for either anti-LFA-1 antibody or anti-VLA-4 antibody during CD44v4-mediated breast cancer cell migration across TNF-α pre-activated HUVEC monolayers (<a href="#pone-0001826-g001">Fig. 1</a>), strongly arguing for a minor role of leukocyte-specific integrins in breast cancer cell metastasis.</p>
<a id="article1.body1.sec3.sec2.p2" name="article1.body1.sec3.sec2.p2"></a><p>In summary, the present study has demonstrated that CD44v4 is a major E-selectin ligand expressed in metastatic breast cancer cells and plays an essential role in regulating tumor cell adhesion to and migration across endothelial monolayers. The results expand our present knowledge of E-selectin-based tumor cell transendothelial metastasis, which might shed some light on the search for new pharmacological approaches to control breast tumor metastasis.</p>

</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Cells</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p>The human breast carcinoma cell lines, MDA-MB-231, MDA-MB-435S, MDA-MB-468, T47D, and MCF-7 were obtained from Dr. Paul Wade (Department of Pathology and Laboratory Medicine, Emory University, Atlanta) and Dr. Xiao Han (Nanjing Medical University, Nanjing, China). Breast cancer cells were grown in Dulbecco's modified Eagle's medium (Gibco BRL, Grand Island, NY) supplemented with 10% fetal bovine serum (Hyclone, Logan, UT), 100 units/ml penicillin and 100 µg/ml streptomycin. Human umbilical vein endothelial cells (HUVECs) were purchased from the China Cell Culture Center (Shanghai, China) and cultured in endothelial medium (Clontech, Mountain View, CA) supplemented with penicillin-streptomycin (100 U/ml and 100 µg/ml, respectively). All media were referred to as complete medium and all of the cell lines used in the study were free of <em>Mycoplasma</em>.</p>


<h4>Antibodies and Reagents</h4>
<a id="article1.body1.sec4.sec2.p1" name="article1.body1.sec4.sec2.p1"></a><p>The monoclonal antibodies used in the experiments and their resources: mouse anti-human E-selectin mAb (MAB575), mouse anti-human CD44H (clone 2C5), mouse anti-human CD44v3 (clone 3G5), mouse anti-human CD44v6 (clone 2F10) and mouse anti-human CD44v4/5 (clone 3D2) (R&amp;D Systems, Minneapolis, MN); Anti-CD44v4 mAb (Lab Vision, Fremont, CA); Anti-human LFA-1 and anti-human VLA-4 mAbs (BD Pharmingen, San Diego, CA); Anti-sLe<sup>x</sup> mAb (Clone KM93) (Chemicon, Temecula, CA); HRP-conjugated goat anti-mouse and anti-rabbit IgG (Jackson ImmunoResearch Lab, West Grove, PA); Alexa Fluor 488(495/519) and Alexa Fluor 568(578/603)-conjugated secondary antibodies (Molecular Probes, Eugene, OR). BCECF-AM, rhodamine-conjugated phalloidin and ProLong antifade reagent were also obtained from Molecular Probes. TNF-α was purchased from Genetech (South San Francisco, CA).</p>


<h4>Soluble Human E-selectin-Fc Chimera Preparation</h4>
<a id="article1.body1.sec4.sec3.p1" name="article1.body1.sec4.sec3.p1"></a><p>cDNA encoding the human E-selectin extracellular domain (residues 1-556) <a href="#pone.0001826-Hession1">[47]</a> was amplified from a human colon cDNA library (Clontech) by PCR using forward primer <span class="gene">5′-ATAT <span class="underline">CATATG</span>AAAAGAACTCTTGAAGTCATG-3′</span> and reverse primer <span class="gene">5′-ATAT<span class="underline">AGATCT</span>AGCTTCACAGGTAGGTAGCAG-3′</span>. The cDNA encoding the E-selectin extracellular domain was fused to a modified rabbit IgG1 Fc region and cloned into pcDNA3.1 (Invitrogen, Carlsbad, CA) using the <em>NdeI</em>/<em>HpaI</em> digestion site. COS-7 cells were used for transfection and fusion protein generation <a href="#pone.0001826-Zen1">[48]</a>. E-selectin/Fc was affinity purified from cell culture supernatants by Protein A-Sepharose (Sigma, St. Louis, MO) and eluted with 100 mM glycine/HCl, pH 3.5, immediately followed by neutralization, concentration and dialysis. As a control, the Fc portion of the fusion protein was also prepared <a href="#pone.0001826-Zen1">[48]</a>. Commercial Recombinant Human E-selectin/CD62E/Fc chimera was obtained from R&amp;D Systems.</p>


<h4>Immunofluorescence and Flow Cytometric Analysis</h4>
<a id="article1.body1.sec4.sec4.p1" name="article1.body1.sec4.sec4.p1"></a><p>For breast cancer cell surface labeling with soluble exE-selectin/Fc, cells grown to confluence on a culture dish were washed three times with cold HBSS and blocked with 5% normal goat serum in HBSS for 30 min on ice. Soluble exE-selectin/Fc and Fc-only (10 µg/ml each) were dissolved in blocking buffer and added to the cell culture dishes. After 1 h incubation on ice, cells were washed three times with HBSS and fixed with 3.7% paraformaldehyde (5 min, 20°C). The bound exE-selectin/Fc or Fc-only was detected by fluorescence conjugated goat anti-rabbit Fc antibody. In some experiments, cells labeled with exE-selectin/Fc were further permeabilized with 0.03% Triton X-100 (5 min, 4°C) and stained with rhodamine conjugated phalloidin (30 min, 4°C). After extensive washing, labeled cells were then mounted in ProLong antifading embedding solution and analyzed using a fluorescence microscope equipped with an imaging system (Olympus, Japan). A 100×NA/1.3 Plan-Neofluar oil immersion lens (Olympus) was used for all images. Images shown are representative of at least three experiments, with multiple images taken per slide. As a control for background labeling, cells were incubated with comparable concentrations of irrelevant IgG and secondary antibody. For flow cytometric analysis, suspended tumor cells (1×10<sup>7</sup> cells; 1 ml) incubated with E-selectin/Fc fusion protein or Fc only were fixed and then incubated for 45 min at 4°C with Alexa Fluor 488-conjugated antibody solution (1:1000 dilution). After three washes, cells were re-suspended and flow cytometry analysis was performed on a FACS instrument. The results were analyzed using CELLQUEST software (BD Biosciences).</p>


<h4>E-selectin Ligand Purification and Identification</h4>
<a id="article1.body1.sec4.sec5.p1" name="article1.body1.sec4.sec5.p1"></a><p>An affinity column was constructed by immobilizing exE-selectin/Fc to protein A-conjugated Sepharose beads. ~500 cm<sup>2</sup> of confluent MDA-MB-231 cells were used for E-selectin ligand isolation. Proteins were eluted from the affinity column at low pH (150 mM NaCl, 100 mM glycine/HCl, pH 3.5, containing 1% <em>n</em>-octylglucoside). The eluant was pH-neutralized and resolved by 10% SDS-PAGE, and the protein bands were visualized by Gelcode 250 staining. The resulting ~170 kD protein band (~100 pmol) was extracted and subjected to direct N-terminal protein sequence analysis.</p>


<h4>Western Blotting</h4>
<a id="article1.body1.sec4.sec6.p1" name="article1.body1.sec4.sec6.p1"></a><p>Cell lysates were homogenized in loading sample buffer, normalized for total protein, and loaded on 10% SDS-PAGE gels. After electrophoresis and transfer onto Hybond nitrocellulose membranes (Amersham, Piscataway, NJ), membranes were blocked with 5% non-fat milk in TTBS, incubated with primary antibody followed by incubation with horseradish peroxidase–conjugated secondary antibody and ECL detection (Amersham). The sLe<sup>x</sup> moieties were detected by mouse anti-sLe<sup>x</sup> antibody, while CD44v was detected using a panel of monoclonal antibodies against various CD44 isoforms including CD44H, respectively.</p>


<h4>siRNA Experiment</h4>
<a id="article1.body1.sec4.sec7.p1" name="article1.body1.sec4.sec7.p1"></a><p>The CD44v4 siRNA experiment was performed as previously described <a href="#pone.0001826-Tzircotis1">[26]</a>. CD44v4 siRNA oligonucleotides, antisense <span class="gene">5′-UAUAUUCAAAUCGAUCUGCTT-3′</span> and sense <span class="gene">5′-GCAGAUCGAUUUGAAUAUATT-3′</span> (GC Content: 31.6%, position 494), were obtained from Sigma. Briefly, annealed siRNA oligonucleotides were transfected into MDA-MB-231 cells seeded in tissue culture plates (35–50% confluent) with 100 µM Lipofectamine 2000 (Invitrogen) in Opti-MEM reduced-serum medium (Invitrogen) <a href="#pone.0001826-Tzircotis1">[26]</a>. Cells were incubated at 37°C for 4 hours before addition of complete medium and cultured for an additional 72 hours before further assays. In the mock transfection control group, oligonucleotides (<span class="gene">5′-UCUACUCUUCCUUCUGCAACCCTT-3′</span> and <span class="gene">5′-GGGUAGCAGAA GGAGUAGATT-3′</span>) (Sigma) were used.</p>


<h4>Protein Binding Assay</h4>
<a id="article1.body1.sec4.sec8.p1" name="article1.body1.sec4.sec8.p1"></a><p>Purified CD44v4 protein (~150 µg/ml in the final solution containing 1% <em>n</em>-octylglucoside) was diluted 1:20 with PBS and 50 µl of diluted solution was immediately added to each well of a 96-well microtiter plate (Costar, Cambridge, MA). Plates were incubated overnight at 4°C to allow protein immobilization. Wells coated with 1% BSA served as controls. After blocking with 1% BSA, plates were incubated with exE-selectin/Fc or Fc only (5 µg/ml each) in blocking solution for 1 h at 37°C. After three washes, bound Fc recombinant was detected by HRP-conjugated goat anti-rabbit Fc antibody and OD measurement. In some experiments, immobilized CD44v4 was treated with neuraminidase for 30 min at 37°C to remove sLe<sup>x</sup> moieties prior to the Fc-recombinant binding assay.</p>


<h4>Cell Adhesion Assay</h4>
<a id="article1.body1.sec4.sec9.p1" name="article1.body1.sec4.sec9.p1"></a><p>The adhesion assay was performed in 96-well plates as previously described <a href="#pone.0001826-Fujisaki1">[46]</a>, <a href="#pone.0001826-Zen2">[49]</a>, <a href="#pone.0001826-Price1">[50]</a>. For cells adhesion to immobilized recombinant E-selectin, 100 µl exE-selectin/Fc or Fc-only (20 µg/ml each) was added to a 96-well microtiter plate and incubated overnight at 4°C to allow protein immobilization. Plates were then blocked with 1% BSA in HBSS for 30 min. For cell adhesion to HUVEC monolayers, 2×10<sup>5</sup> HUVECs cells were grown to confluence on collagen-coated Transwell membranes, and then treated for 6 h with 25ng/ml TNF-α <a href="#pone.0001826-Ryu1">[51]</a>, <a href="#pone.0001826-Yang1">[52]</a>. Suspended breast cancer cells were pre-labeled with 2.5 µM BCECF-AM for 10 min at 37°C. After three washes, cells were re-suspended in HBSS containing 1% BSA at a concentration of 2×10<sup>5</sup> cells/ml. 150 µl of the cell suspension was added to 96-well plates or the upper chamber of Transwell setups. After 1 h incubation in the presence of various antibodies at 25 µg/ml each, plates and Transwell filters were washed three times to remove unbound tumor cells. The fluorescence of plates was read directly on a Fluorescence Measurement System (Millipore, Cytofluor 2300) at wavelengths of 485/538 nm excitation/emission. For Transwell setups, cells were elicited by trypsin/EDTA and re-suspended in 150 µl HBSS for fluorescence measurement.</p>


<h4>Transmigration assay</h4>
<a id="article1.body1.sec4.sec10.p1" name="article1.body1.sec4.sec10.p1"></a><p>Transendothelial migration assays of breast cancer cells were performed as described previously with a minor modification <a href="#pone.0001826-Roetger1">[53]</a>. Briefly, 5.0 µm pore-size Transwell filters were coated with rat collagen at a concentration of 150 µg/cm<sup>2</sup> by drying overnight under a laminar flow hood. HUVECs were seeded onto rehydrated coated membranes at a concentration of 2×10<sup>5</sup> cells/well. After confluent monolayer formation, HUVEC monolayers were treated with 25 ng/ml TNF-α for 6 h <a href="#pone.0001826-Ryu1">[51]</a>, <a href="#pone.0001826-Yang1">[52]</a>. Invasion assays of breast cancer cells were performed by applying approximately 10<sup>6</sup> disaggregated cells to the upper reservoir. The invasion medium was placed in the wells on both sides of the membranes. Invasion assays were incubated overnight at 37°C and, thereafter, HUVEC monolayers and non-invading cells on the upper surface of the membrane were removed. Migrated tumor cells on the bottom side of the membranes and in the lower chamber were collected, stained and calculated under a microscope <a href="#pone.0001826-Wang1">[15]</a>.</p>


<h4>Statistics</h4>
<a id="article1.body1.sec4.sec11.p1" name="article1.body1.sec4.sec11.p1"></a><p>The data are expressed as the mean±SD of at least three experiments performed in quadruplicate. Statistical analysis of the significance of differences between groups was carried out using a Student's <em>t</em> test. A <em>p</em>&lt;0.05 was considered significant.</p>

</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>The authors thank Dr. Paul Wade (Department of Pathology, Emory University) and Professor Xiao Han (Nanjing Medical University, Nanjing, China) for providing all breast cancer cell lines.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: KZ YL CZ. Performed the experiments: KZ DL YG CW JS MF. Analyzed the data: KZ DL YG CW JS CZ. Contributed reagents/materials/analysis tools: YL. Wrote the paper: KZ.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001826-Nubel1" id="pone.0001826-Nubel1"></a>Nubel T, Dippold W, Kleinert H, Kaina B, Fritz G (2004) Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion. Faseb J  18: 140–142.  <ul class="find" data-citedArticleID="1077110" data-doi="10.1096/fj.03-0261fje"><li><a href="http://dx.doi.org/10.1096/fj.03-0261fje" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Lovastatin+inhibits+Rho-regulated+expression+of+E-selectin+by+TNFalpha+and+attenuates+tumor+cell+adhesion." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Lovastatin+inhibits+Rho-regulated+expression+of+E-selectin+by+TNFalpha+and+attenuates+tumor+cell+adhesion.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001826-Laferriere1" id="pone.0001826-Laferriere1"></a>Laferriere J, Houle F, Huot J (2002) Regulation of the metastatic process by E-selectin and stress-activated protein kinase-2/p38. Ann N Y Acad Sci  973: 562–572.  <ul class="find" data-citedArticleID="1077086" data-doi="10.1111/j.1749-6632.2002.tb04702.x"><li><a href="http://dx.doi.org/10.1111/j.1749-6632.2002.tb04702.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Regulation+of+the+metastatic+process+by+E-selectin+and+stress-activated+protein+kinase-2%2Fp38." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Regulation+of+the+metastatic+process+by+E-selectin+and+stress-activated+protein+kinase-2%2Fp38.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001826-Laferriere2" id="pone.0001826-Laferriere2"></a>Laferriere J, Houle F, Taher MM, Valerie K, Huot J (2001) Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem  276: 33762–33772.  <ul class="find" data-citedArticleID="1077088" data-doi="10.1074/jbc.m008564200"><li><a href="http://dx.doi.org/10.1074/jbc.m008564200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Transendothelial+migration+of+colon+carcinoma+cells+requires+expression+of+E-selectin+by+endothelial+cells+and+activation+of+stress-activated+protein+kinase-2+%28SAPK2%2Fp38%29+in+the+tumor+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Transendothelial+migration+of+colon+carcinoma+cells+requires+expression+of+E-selectin+by+endothelial+cells+and+activation+of+stress-activated+protein+kinase-2+%28SAPK2%2Fp38%29+in+the+tumor+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001826-Lesley1" id="pone.0001826-Lesley1"></a>Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with extracellular matrix. Adv Immunol  54: 271–335.  <ul class="find" data-citedArticleID="1077094" data-doi="10.1016/s0065-2776(08)60537-4"><li><a href="http://dx.doi.org/10.1016/s0065-2776(08)60537-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44+and+its+interaction+with+extracellular+matrix." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44+and+its+interaction+with+extracellular+matrix.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001826-Tozawa1" id="pone.0001826-Tozawa1"></a>Tozawa K, Okamoto T, Kawai N, Hashimoto Y, Hayashi Y, et al.  (2005) Positive correlation between sialyl Lewis X expression and pathologic findings in renal cell carcinoma. Kidney Int  67: 1391–1396.  <ul class="find" data-citedArticleID="1077124" data-doi="10.1111/j.1523-1755.2005.00216.x"><li><a href="http://dx.doi.org/10.1111/j.1523-1755.2005.00216.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Positive+correlation+between+sialyl+Lewis+X+expression+and+pathologic+findings+in+renal+cell+carcinoma." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Positive+correlation+between+sialyl+Lewis+X+expression+and+pathologic+findings+in+renal+cell+carcinoma.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001826-Koike1" id="pone.0001826-Koike1"></a>Koike T, Kimura N, Miyazaki K, Yabuta T, Kumamoto K, et al.  (2004) Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci U S A  101: 8132–8137.  <ul class="find" data-citedArticleID="1077082" data-doi="10.1073/pnas.0402088101"><li><a href="http://dx.doi.org/10.1073/pnas.0402088101" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Hypoxia+induces+adhesion+molecules+on+cancer+cells%3A+A+missing+link+between+Warburg+effect+and+induction+of+selectin-ligand+carbohydrates." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Hypoxia+induces+adhesion+molecules+on+cancer+cells%3A+A+missing+link+between+Warburg+effect+and+induction+of+selectin-ligand+carbohydrates.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001826-Tozeren1" id="pone.0001826-Tozeren1"></a>Tozeren A, Kleinman HK, Grant DS, Morales D, Mercurio AM, et al.  (1995) E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int J Cancer  60: 426–431.  <ul class="find" data-citedArticleID="1077126" data-doi="10.1002/ijc.2910600326"><li><a href="http://dx.doi.org/10.1002/ijc.2910600326" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=E-selectin-mediated+dynamic+interactions+of+breast-+and+colon-cancer+cells+with+endothelial-cell+monolayers." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22E-selectin-mediated+dynamic+interactions+of+breast-+and+colon-cancer+cells+with+endothelial-cell+monolayers.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001826-Moss1" id="pone.0001826-Moss1"></a>Moss MA, Zimmer S, Anderson KW (2000) Role of metastatic potential in the adhesion of human breast cancer cells to endothelial monolayers. Anticancer Res  20: 1425–1433.  <ul class="find" data-citedArticleID="1077104"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Role+of+metastatic+potential+in+the+adhesion+of+human+breast+cancer+cells+to+endothelial+monolayers.&amp;auth=&amp;atitle=Role+of+metastatic+potential+in+the+adhesion+of+human+breast+cancer+cells+to+endothelial+monolayers." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Role+of+metastatic+potential+in+the+adhesion+of+human+breast+cancer+cells+to+endothelial+monolayers." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Role+of+metastatic+potential+in+the+adhesion+of+human+breast+cancer+cells+to+endothelial+monolayers.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001826-McEver1" id="pone.0001826-McEver1"></a>McEver RP (2002) P-selectin and PSGL-1: exploiting connections between inflammation and venous thrombosis. Thromb Haemost  87: 364–365.  <ul class="find" data-citedArticleID="1077100"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=P-selectin+and+PSGL-1%3A+exploiting+connections+between+inflammation+and+venous+thrombosis.&amp;auth=&amp;atitle=P-selectin+and+PSGL-1%3A+exploiting+connections+between+inflammation+and+venous+thrombosis." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=P-selectin+and+PSGL-1%3A+exploiting+connections+between+inflammation+and+venous+thrombosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22P-selectin+and+PSGL-1%3A+exploiting+connections+between+inflammation+and+venous+thrombosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001826-Dimitroff1" id="pone.0001826-Dimitroff1"></a>Dimitroff CJ, Descheny L, Trujillo N, Kim R, Nguyen V, et al.  (2005) Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Res  65: 5750–5760.  <ul class="find" data-citedArticleID="1077048" data-doi="10.1158/0008-5472.can-04-4653"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-04-4653" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Identification+of+leukocyte+E-selectin+ligands%2C+P-selectin+glycoprotein+ligand-1+and+E-selectin+ligand-1%2C+on+human+metastatic+prostate+tumor+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Identification+of+leukocyte+E-selectin+ligands%2C+P-selectin+glycoprotein+ligand-1+and+E-selectin+ligand-1%2C+on+human+metastatic+prostate+tumor+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001826-Hanley1" id="pone.0001826-Hanley1"></a>Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R (2005) CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity. Cancer Res  65: 5812–5817.  <ul class="find" data-citedArticleID="1077066" data-doi="10.1158/0008-5472.can-04-4557"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-04-4557" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44+on+LS174T+colon+carcinoma+cells+possesses+E-selectin+ligand+activity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44+on+LS174T+colon+carcinoma+cells+possesses+E-selectin+ligand+activity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001826-Napier1" id="pone.0001826-Napier1"></a>Napier SL, Healy ZR, Schnaar RL, Konstantopoulos K (2007) Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands. J Biol Chem  282: 3433–3441.  <ul class="find" data-citedArticleID="1077108" data-doi="10.1074/jbc.m607219200"><li><a href="http://dx.doi.org/10.1074/jbc.m607219200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Selectin+ligand+expression+regulates+the+initial+vascular+interactions+of+colon+carcinoma+cells%3A+the+roles+of+CD44v+and+alternative+sialofucosylated+selectin+ligands." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Selectin+ligand+expression+regulates+the+initial+vascular+interactions+of+colon+carcinoma+cells%3A+the+roles+of+CD44v+and+alternative+sialofucosylated+selectin+ligands.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001826-Bajorath1" id="pone.0001826-Bajorath1"></a>Bajorath J (2000) Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins  39: 103–111.  <ul class="find" data-citedArticleID="1077042" data-doi="10.1002/(sici)1097-0134(20000501)39:2<103::aid-prot1&gt;3.0.co;2-g"><li><a href="http://dx.doi.org/10.1002/(sici)1097-0134(20000501)39:2<103::aid-prot1&gt;3.0.co;2-g" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Molecular+organization%2C+structural+features%2C+and+ligand+binding+characteristics+of+CD44%2C+a+highly+variable+cell+surface+glycoprotein+with+multiple+functions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Molecular+organization%2C+structural+features%2C+and+ligand+binding+characteristics+of+CD44%2C+a+highly+variable+cell+surface+glycoprotein+with+multiple+functions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001826-Khan1" id="pone.0001826-Khan1"></a>Khan AI, Kerfoot SM, Heit B, Liu L, Andonegui G, et al.  (2004) Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol  173: 7594–7601.  <ul class="find" data-citedArticleID="1077080"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Role+of+CD44+and+hyaluronan+in+neutrophil+recruitment.&amp;auth=&amp;atitle=Role+of+CD44+and+hyaluronan+in+neutrophil+recruitment." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Role+of+CD44+and+hyaluronan+in+neutrophil+recruitment." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Role+of+CD44+and+hyaluronan+in+neutrophil+recruitment.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001826-Wang1" id="pone.0001826-Wang1"></a>Wang HS, Hung Y, Su CH, Peng ST, Guo YJ, et al.  (2005) CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1). Exp Cell Res  304: 116–126.  <ul class="find" data-citedArticleID="1077138" data-doi="10.1016/j.yexcr.2004.10.015"><li><a href="http://dx.doi.org/10.1016/j.yexcr.2004.10.015" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44+cross-linking+induces+integrin-mediated+adhesion+and+transendothelial+migration+in+breast+cancer+cell+line+by+up-regulation+of+LFA-1+%28alpha+L+beta2%29+and+VLA-4+%28alpha4beta1%29." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44+cross-linking+induces+integrin-mediated+adhesion+and+transendothelial+migration+in+breast+cancer+cell+line+by+up-regulation+of+LFA-1+%28alpha+L+beta2%29+and+VLA-4+%28alpha4beta1%29.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001826-Naor1" id="pone.0001826-Naor1"></a>Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res  71: 241–319.  <ul class="find" data-citedArticleID="1077106" data-doi="10.1016/s0065-230x(08)60101-3"><li><a href="http://dx.doi.org/10.1016/s0065-230x(08)60101-3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44%3A+structure%2C+function%2C+and+association+with+the+malignant+process." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44%3A+structure%2C+function%2C+and+association+with+the+malignant+process.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001826-Spessotto1" id="pone.0001826-Spessotto1"></a>Spessotto P, Rossi FM, Degan M, Di Francia R, Perris R, et al.  (2002) Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol  158: 1133–1144.  <ul class="find" data-citedArticleID="1077122" data-doi="10.1083/jcb.200202120"><li><a href="http://dx.doi.org/10.1083/jcb.200202120" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Hyaluronan-CD44+interaction+hampers+migration+of+osteoclast-like+cells+by+down-regulating+MMP-9." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Hyaluronan-CD44+interaction+hampers+migration+of+osteoclast-like+cells+by+down-regulating+MMP-9.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001826-Underhill1" id="pone.0001826-Underhill1"></a>Underhill C (1992) CD44: the hyaluronan receptor. J Cell Sci  103 ( Pt 2): 293–298.  <ul class="find" data-citedArticleID="1077134"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=CD44%3A+the+hyaluronan+receptor.&amp;auth=&amp;atitle=CD44%3A+the+hyaluronan+receptor." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44%3A+the+hyaluronan+receptor." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44%3A+the+hyaluronan+receptor.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001826-Mine1" id="pone.0001826-Mine1"></a>Mine S, Fujisaki T, Kawahara C, Tabata T, Iida T, et al.  (2003) Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44. Exp Cell Res  288: 189–197.  <ul class="find" data-citedArticleID="1077102" data-doi="10.1016/s0014-4827(03)00184-8"><li><a href="http://dx.doi.org/10.1016/s0014-4827(03)00184-8" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Hepatocyte+growth+factor+enhances+adhesion+of+breast+cancer+cells+to+endothelial+cells+in+vitro+through+up-regulation+of+CD44." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Hepatocyte+growth+factor+enhances+adhesion+of+breast+cancer+cells+to+endothelial+cells+in+vitro+through+up-regulation+of+CD44.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001826-Guo1" id="pone.0001826-Guo1"></a>Guo Y, Ma J, Wang J, Che X, Narula J, et al.  (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res  54: 1561–1565.  <ul class="find" data-citedArticleID="1077064"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Inhibition+of+human+melanoma+growth+and+metastasis+in+vivo+by+anti-CD44+monoclonal+antibody.&amp;auth=&amp;atitle=Inhibition+of+human+melanoma+growth+and+metastasis+in+vivo+by+anti-CD44+monoclonal+antibody." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Inhibition+of+human+melanoma+growth+and+metastasis+in+vivo+by+anti-CD44+monoclonal+antibody." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Inhibition+of+human+melanoma+growth+and+metastasis+in+vivo+by+anti-CD44+monoclonal+antibody.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001826-Zahalka1" id="pone.0001826-Zahalka1"></a>Zahalka MA, Okon E, Gosslar U, Holzmann B, Naor D (1995) Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J Immunol  154: 5345–5355.  <ul class="find" data-citedArticleID="1077142"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Lymph+node+%28but+not+spleen%29+invasion+by+murine+lymphoma+is+both+CD44-+and+hyaluronate-dependent.&amp;auth=&amp;atitle=Lymph+node+%28but+not+spleen%29+invasion+by+murine+lymphoma+is+both+CD44-+and+hyaluronate-dependent." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Lymph+node+%28but+not+spleen%29+invasion+by+murine+lymphoma+is+both+CD44-+and+hyaluronate-dependent." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Lymph+node+%28but+not+spleen%29+invasion+by+murine+lymphoma+is+both+CD44-+and+hyaluronate-dependent.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001826-Lechertier1" id="pone.0001826-Lechertier1"></a>Lechertier T, Berard M, Vassy R, Herve MA, Crepin M (2004) Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes. Anticancer Res  24: 4011–4017.  <ul class="find" data-citedArticleID="1077092"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Transendothelial+migration+of+two+metastatic+breast+carcinoma+cells+depend+on+the+SDF-lalpha-CXCR4+complexes.&amp;auth=&amp;atitle=Transendothelial+migration+of+two+metastatic+breast+carcinoma+cells+depend+on+the+SDF-lalpha-CXCR4+complexes." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Transendothelial+migration+of+two+metastatic+breast+carcinoma+cells+depend+on+the+SDF-lalpha-CXCR4+complexes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Transendothelial+migration+of+two+metastatic+breast+carcinoma+cells+depend+on+the+SDF-lalpha-CXCR4+complexes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001826-Krop1" id="pone.0001826-Krop1"></a>Krop I, Marz A, Carlsson H, Li X, Bloushtain-Qimron N, et al.  (2005) A putative role for psoriasin in breast tumor progression. Cancer Res  65: 11326–11334.  <ul class="find" data-citedArticleID="1077084" data-doi="10.1158/0008-5472.can-05-1523"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-05-1523" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+putative+role+for+psoriasin+in+breast+tumor+progression." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+putative+role+for+psoriasin+in+breast+tumor+progression.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001826-Edberg1" id="pone.0001826-Edberg1"></a>Edberg DD, Adkins JN, Springer DL, Reeves R (2005) Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins. J Biol Chem  280: 8961–8973.  <ul class="find" data-citedArticleID="1077052" data-doi="10.1074/jbc.m407348200"><li><a href="http://dx.doi.org/10.1074/jbc.m407348200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Dynamic+and+differential+in+vivo+modifications+of+the+isoform+HMGA1a+and+HMGA1b+chromatin+proteins." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Dynamic+and+differential+in+vivo+modifications+of+the+isoform+HMGA1a+and+HMGA1b+chromatin+proteins.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001826-Bouker1" id="pone.0001826-Bouker1"></a>Bouker KB, Skaar TC, Riggins RB, Harburger DS, Fernandez DR, et al.  (2005) Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis  26: 1527–1535.  <ul class="find" data-citedArticleID="1077044" data-doi="10.1093/carcin/bgi113"><li><a href="http://dx.doi.org/10.1093/carcin/bgi113" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Interferon+regulatory+factor-1+%28IRF-1%29+exhibits+tumor+suppressor+activities+in+breast+cancer+associated+with+caspase+activation+and+induction+of+apoptosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Interferon+regulatory+factor-1+%28IRF-1%29+exhibits+tumor+suppressor+activities+in+breast+cancer+associated+with+caspase+activation+and+induction+of+apoptosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001826-Tzircotis1" id="pone.0001826-Tzircotis1"></a>Tzircotis G, Thorne RF, Isacke CM (2005) Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. J Cell Sci  118: 5119–5128.  <ul class="find" data-citedArticleID="1077130" data-doi="10.1242/jcs.02629"><li><a href="http://dx.doi.org/10.1242/jcs.02629" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Chemotaxis+towards+hyaluronan+is+dependent+on+CD44+expression+and+modulated+by+cell+type+variation+in+CD44-hyaluronan+binding." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Chemotaxis+towards+hyaluronan+is+dependent+on+CD44+expression+and+modulated+by+cell+type+variation+in+CD44-hyaluronan+binding.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001826-Edwards1" id="pone.0001826-Edwards1"></a>Edwards DR, Murphy G (1998) Cancer. Proteases–invasion and more. Nature  394: 527–528.  <ul class="find" data-citedArticleID="1077054" data-doi="10.1038/28961"><li><a href="http://dx.doi.org/10.1038/28961" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cancer.+Proteases%E2%80%93invasion+and+more." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cancer.+Proteases%E2%80%93invasion+and+more.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001826-Dumont1" id="pone.0001826-Dumont1"></a>Dumont N, Arteaga CL (2003) Targeting the TGF beta signaling network in human neoplasia. Cancer Cell  3: 531–536.  <ul class="find" data-citedArticleID="1077050" data-doi="10.1016/s1535-6108(03)00135-1"><li><a href="http://dx.doi.org/10.1016/s1535-6108(03)00135-1" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Targeting+the+TGF+beta+signaling+network+in+human+neoplasia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Targeting+the+TGF+beta+signaling+network+in+human+neoplasia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001826-Kang1" id="pone.0001826-Kang1"></a>Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, et al.  (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell  3: 537–549.  <ul class="find" data-citedArticleID="1077078" data-doi="10.1016/s1535-6108(03)00132-6"><li><a href="http://dx.doi.org/10.1016/s1535-6108(03)00132-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+multigenic+program+mediating+breast+cancer+metastasis+to+bone." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+multigenic+program+mediating+breast+cancer+metastasis+to+bone.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001826-Tremblay1" id="pone.0001826-Tremblay1"></a>Tremblay PL, Auger FA, Huot J (2006) Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene  25: 6563–6573.  <ul class="find" data-citedArticleID="1077128" data-doi="10.1038/sj.onc.1209664"><li><a href="http://dx.doi.org/10.1038/sj.onc.1209664" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Regulation+of+transendothelial+migration+of+colon+cancer+cells+by+E-selectin-mediated+activation+of+p38+and+ERK+MAP+kinases." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Regulation+of+transendothelial+migration+of+colon+cancer+cells+by+E-selectin-mediated+activation+of+p38+and+ERK+MAP+kinases.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001826-Rosen1" id="pone.0001826-Rosen1"></a>Rosen SD, Bertozzi CR (1994) The selectins and their ligands. Curr Opin Cell Biol  6: 663–673.  <ul class="find" data-citedArticleID="1077116" data-doi="10.1016/0955-0674(94)90092-2"><li><a href="http://dx.doi.org/10.1016/0955-0674(94)90092-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+selectins+and+their+ligands." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+selectins+and+their+ligands.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0001826-LauerFields1" id="pone.0001826-LauerFields1"></a>Lauer-Fields JL, Malkar NB, Richet G, Drauz K, Fields GB (2003) Melanoma cell CD44 interaction with the alpha 1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation. J Biol Chem  278: 14321–14330.  <ul class="find" data-citedArticleID="1077090" data-doi="10.1074/jbc.m212246200"><li><a href="http://dx.doi.org/10.1074/jbc.m212246200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Melanoma+cell+CD44+interaction+with+the+alpha+1%28IV%291263-1277+region+from+basement+membrane+collagen+is+modulated+by+ligand+glycosylation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Melanoma+cell+CD44+interaction+with+the+alpha+1%28IV%291263-1277+region+from+basement+membrane+collagen+is+modulated+by+ligand+glycosylation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0001826-Jalkanen1" id="pone.0001826-Jalkanen1"></a>Jalkanen S, Jalkanen M (1992) Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol  116: 817–825.  <ul class="find" data-citedArticleID="1077074" data-doi="10.1083/jcb.116.3.817"><li><a href="http://dx.doi.org/10.1083/jcb.116.3.817" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Lymphocyte+CD44+binds+the+COOH-terminal+heparin-binding+domain+of+fibronectin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Lymphocyte+CD44+binds+the+COOH-terminal+heparin-binding+domain+of+fibronectin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0001826-Hibino1" id="pone.0001826-Hibino1"></a>Hibino S, Shibuya M, Hoffman MP, Engbring JA, Hossain R, et al.  (2005) Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44. Cancer Res  65: 10494–10501.  <ul class="find" data-citedArticleID="1077072" data-doi="10.1158/0008-5472.can-05-0314"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-05-0314" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Laminin+alpha5+chain+metastasis-+and+angiogenesis-inhibiting+peptide+blocks+fibroblast+growth+factor+2+activity+by+binding+to+the+heparan+sulfate+chains+of+CD44." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Laminin+alpha5+chain+metastasis-+and+angiogenesis-inhibiting+peptide+blocks+fibroblast+growth+factor+2+activity+by+binding+to+the+heparan+sulfate+chains+of+CD44.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0001826-Fujimoto1" id="pone.0001826-Fujimoto1"></a>Fujimoto T, Kawashima H, Tanaka T, Hirose M, Toyama-Sorimachi N, et al.  (2001) CD44 binds a chondroitin sulfate proteoglycan, aggrecan. Int Immunol  13: 359–366.  <ul class="find" data-citedArticleID="1077058" data-doi="10.1093/intimm/13.3.359"><li><a href="http://dx.doi.org/10.1093/intimm/13.3.359" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44+binds+a+chondroitin+sulfate+proteoglycan%2C+aggrecan." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44+binds+a+chondroitin+sulfate+proteoglycan%2C+aggrecan.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0001826-Marhaba1" id="pone.0001826-Marhaba1"></a>Marhaba R, Zoller M (2004) CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol  35: 211–231.  <ul class="find" data-citedArticleID="1077098" data-doi="10.1023/b:hijo.0000032354.94213.69"><li><a href="http://dx.doi.org/10.1023/b:hijo.0000032354.94213.69" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44+in+cancer+progression%3A+adhesion%2C+migration+and+growth+regulation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44+in+cancer+progression%3A+adhesion%2C+migration+and+growth+regulation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0001826-Gotte1" id="pone.0001826-Gotte1"></a>Gotte M, Yip GW (2006) Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res  66: 10233–10237.  <ul class="find" data-citedArticleID="1077062" data-doi="10.1158/0008-5472.can-06-1464"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-06-1464" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Heparanase%2C+hyaluronan%2C+and+CD44+in+cancers%3A+a+breast+carcinoma+perspective." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Heparanase%2C+hyaluronan%2C+and+CD44+in+cancers%3A+a+breast+carcinoma+perspective.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0001826-Diaz1" id="pone.0001826-Diaz1"></a>Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, et al.  (2005) CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Clin Cancer Res  11: 3309–3314.  <ul class="find" data-citedArticleID="1077046" data-doi="10.1158/1078-0432.ccr-04-2184"><li><a href="http://dx.doi.org/10.1158/1078-0432.ccr-04-2184" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44+expression+is+associated+with+increased+survival+in+node-negative+invasive+breast+carcinoma." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44+expression+is+associated+with+increased+survival+in+node-negative+invasive+breast+carcinoma.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0001826-Liu1" id="pone.0001826-Liu1"></a>Liu R, Wang X, Chen GY, Dalerba P, Gurney A, et al.  (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med  356: 217–226.  <ul class="find" data-citedArticleID="1077096" data-doi="10.1056/nejmoa063994"><li><a href="http://dx.doi.org/10.1056/nejmoa063994" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+prognostic+role+of+a+gene+signature+from+tumorigenic+breast-cancer+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+prognostic+role+of+a+gene+signature+from+tumorigenic+breast-cancer+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0001826-Seiter1" id="pone.0001826-Seiter1"></a>Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, et al.  (1993) Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med  177: 443–455.  <ul class="find" data-citedArticleID="1077120" data-doi="10.1084/jem.177.2.443"><li><a href="http://dx.doi.org/10.1084/jem.177.2.443" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Prevention+of+tumor+metastasis+formation+by+anti-variant+CD44." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Prevention+of+tumor+metastasis+formation+by+anti-variant+CD44.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">41.
              </span><a name="pone.0001826-WallachDayan1" id="pone.0001826-WallachDayan1"></a>Wallach-Dayan SB, Grabovsky V, Moll J, Sleeman J, Herrlich P, et al.  (2001) CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. J Cell Sci  114: 3463–3477.  <ul class="find" data-citedArticleID="1077136"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=CD44-dependent+lymphoma+cell+dissemination%3A+a+cell+surface+CD44+variant%2C+rather+than+standard+CD44%2C+supports+in+vitro+lymphoma+cell+rolling+on+hyaluronic+acid+substrate+and+its+in+vivo+accumulation+in+the+peripheral+lymph+nodes.&amp;auth=&amp;atitle=CD44-dependent+lymphoma+cell+dissemination%3A+a+cell+surface+CD44+variant%2C+rather+than+standard+CD44%2C+supports+in+vitro+lymphoma+cell+rolling+on+hyaluronic+acid+substrate+and+its+in+vivo+accumulation+in+the+peripheral+lymph+nodes." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44-dependent+lymphoma+cell+dissemination%3A+a+cell+surface+CD44+variant%2C+rather+than+standard+CD44%2C+supports+in+vitro+lymphoma+cell+rolling+on+hyaluronic+acid+substrate+and+its+in+vivo+accumulation+in+the+peripheral+lymph+nodes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44-dependent+lymphoma+cell+dissemination%3A+a+cell+surface+CD44+variant%2C+rather+than+standard+CD44%2C+supports+in+vitro+lymphoma+cell+rolling+on+hyaluronic+acid+substrate+and+its+in+vivo+accumulation+in+the+peripheral+lymph+nodes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">42.
              </span><a name="pone.0001826-HerreraGayol1" id="pone.0001826-HerreraGayol1"></a>Herrera-Gayol A, Jothy S (1999) CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness. Exp Mol Pathol  66: 99–108.  <ul class="find" data-citedArticleID="1077068" data-doi="10.1006/exmp.1999.2236"><li><a href="http://dx.doi.org/10.1006/exmp.1999.2236" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44+modulates+Hs578T+human+breast+cancer+cell+adhesion%2C+migration%2C+and+invasiveness." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44+modulates+Hs578T+human+breast+cancer+cell+adhesion%2C+migration%2C+and+invasiveness.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">43.
              </span><a name="pone.0001826-Jensen1" id="pone.0001826-Jensen1"></a>Jensen PV, Larsson LI (2004) Actin microdomains on endothelial cells: association with CD44, ERM proteins, and signaling molecules during quiescence and wound healing. Histochem Cell Biol  121: 361–369.  <ul class="find" data-citedArticleID="1077076" data-doi="10.1007/s00418-004-0648-2"><li><a href="http://dx.doi.org/10.1007/s00418-004-0648-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Actin+microdomains+on+endothelial+cells%3A+association+with+CD44%2C+ERM+proteins%2C+and+signaling+molecules+during+quiescence+and+wound+healing." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Actin+microdomains+on+endothelial+cells%3A+association+with+CD44%2C+ERM+proteins%2C+and+signaling+molecules+during+quiescence+and+wound+healing.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">44.
              </span><a name="pone.0001826-Tzircotis2" id="pone.0001826-Tzircotis2"></a>Tzircotis G, Thorne RF, Isacke CM (2006) Directional sensing of a phorbol ester gradient requires CD44 and is regulated by CD44 phosphorylation. Oncogene  25: 7401–7410.  <ul class="find" data-citedArticleID="1077132" data-doi="10.1038/sj.onc.1209724"><li><a href="http://dx.doi.org/10.1038/sj.onc.1209724" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Directional+sensing+of+a+phorbol+ester+gradient+requires+CD44+and+is+regulated+by+CD44+phosphorylation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Directional+sensing+of+a+phorbol+ester+gradient+requires+CD44+and+is+regulated+by+CD44+phosphorylation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">45.
              </span><a name="pone.0001826-Fanning1" id="pone.0001826-Fanning1"></a>Fanning A, Volkov Y, Freeley M, Kelleher D, Long A (2005) CD44 cross-linking induces protein kinase C-regulated migration of human T lymphocytes. Int Immunol  17: 449–458.  <ul class="find" data-citedArticleID="1077056" data-doi="10.1093/intimm/dxh225"><li><a href="http://dx.doi.org/10.1093/intimm/dxh225" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44+cross-linking+induces+protein+kinase+C-regulated+migration+of+human+T+lymphocytes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44+cross-linking+induces+protein+kinase+C-regulated+migration+of+human+T+lymphocytes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">46.
              </span><a name="pone.0001826-Fujisaki1" id="pone.0001826-Fujisaki1"></a>Fujisaki T, Tanaka Y, Fujii K, Mine S, Saito K, et al.  (1999) CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res  59: 4427–4434.  <ul class="find" data-citedArticleID="1077060"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=CD44+stimulation+induces+integrin-mediated+adhesion+of+colon+cancer+cell+lines+to+endothelial+cells+by+up-regulation+of+integrins+and+c-Met+and+activation+of+integrins.&amp;auth=&amp;atitle=CD44+stimulation+induces+integrin-mediated+adhesion+of+colon+cancer+cell+lines+to+endothelial+cells+by+up-regulation+of+integrins+and+c-Met+and+activation+of+integrins." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD44+stimulation+induces+integrin-mediated+adhesion+of+colon+cancer+cell+lines+to+endothelial+cells+by+up-regulation+of+integrins+and+c-Met+and+activation+of+integrins." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD44+stimulation+induces+integrin-mediated+adhesion+of+colon+cancer+cell+lines+to+endothelial+cells+by+up-regulation+of+integrins+and+c-Met+and+activation+of+integrins.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">47.
              </span><a name="pone.0001826-Hession1" id="pone.0001826-Hession1"></a>Hession C, Osborn L, Goff D, Chi-Rosso G, Vassallo C, et al.  (1990) Endothelial leukocyte adhesion molecule 1: direct expression cloning and functional interactions. Proc Natl Acad Sci U S A  87: 1673–1677.  <ul class="find" data-citedArticleID="1077070" data-doi="10.1073/pnas.87.5.1673"><li><a href="http://dx.doi.org/10.1073/pnas.87.5.1673" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Endothelial+leukocyte+adhesion+molecule+1%3A+direct+expression+cloning+and+functional+interactions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Endothelial+leukocyte+adhesion+molecule+1%3A+direct+expression+cloning+and+functional+interactions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">48.
              </span><a name="pone.0001826-Zen1" id="pone.0001826-Zen1"></a>Zen K, Babbin BA, Liu Y, Whelan JB, Nusrat A, et al.  (2004) JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol Biol Cell  15: 3926–3937.  <ul class="find" data-citedArticleID="1077144" data-doi="10.1091/mbc.e04-04-0317"><li><a href="http://dx.doi.org/10.1091/mbc.e04-04-0317" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=JAM-C+is+a+component+of+desmosomes+and+a+ligand+for+CD11b%2FCD18-mediated+neutrophil+transepithelial+migration." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22JAM-C+is+a+component+of+desmosomes+and+a+ligand+for+CD11b%2FCD18-mediated+neutrophil+transepithelial+migration.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">49.
              </span><a name="pone.0001826-Zen2" id="pone.0001826-Zen2"></a>Zen K, Liu Y, Cairo D, Parkos CA (2002) CD11b/CD18-dependent interactions of neutrophils with intestinal epithelium are mediated by fucosylated proteoglycans. J Immunol  169: 5270–5278.  <ul class="find" data-citedArticleID="1077146"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=CD11b%2FCD18-dependent+interactions+of+neutrophils+with+intestinal+epithelium+are+mediated+by+fucosylated+proteoglycans.&amp;auth=&amp;atitle=CD11b%2FCD18-dependent+interactions+of+neutrophils+with+intestinal+epithelium+are+mediated+by+fucosylated+proteoglycans." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD11b%2FCD18-dependent+interactions+of+neutrophils+with+intestinal+epithelium+are+mediated+by+fucosylated+proteoglycans." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD11b%2FCD18-dependent+interactions+of+neutrophils+with+intestinal+epithelium+are+mediated+by+fucosylated+proteoglycans.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">50.
              </span><a name="pone.0001826-Price1" id="pone.0001826-Price1"></a>Price EA, Coombe DR, Murray JC (1996) Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro. Int J Cancer  65: 513–518.  <ul class="find" data-citedArticleID="1077112" data-doi="10.1002/(sici)1097-0215(19960208)65:4<513::aid-ijc20&gt;3.0.co;2-9"><li><a href="http://dx.doi.org/10.1002/(sici)1097-0215(19960208)65:4<513::aid-ijc20&gt;3.0.co;2-9" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Endothelial+CD44H+mediates+adhesion+of+a+melanoma+cell+line+to+quiescent+human+endothelial+cells+in+vitro." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Endothelial+CD44H+mediates+adhesion+of+a+melanoma+cell+line+to+quiescent+human+endothelial+cells+in+vitro.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">51.
              </span><a name="pone.0001826-Ryu1" id="pone.0001826-Ryu1"></a>Ryu JW, Hong KH, Maeng JH, Kim JB, Ko J, et al.  (2004) Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration. Arterioscler Thromb Vasc Biol  24: 864–870.  <ul class="find" data-citedArticleID="1077118" data-doi="10.1161/01.atv.0000125705.28058.eb"><li><a href="http://dx.doi.org/10.1161/01.atv.0000125705.28058.eb" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Overexpression+of+uncoupling+protein+2+in+THP1+monocytes+inhibits+beta2+integrin-mediated+firm+adhesion+and+transendothelial+migration." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Overexpression+of+uncoupling+protein+2+in+THP1+monocytes+inhibits+beta2+integrin-mediated+firm+adhesion+and+transendothelial+migration.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">52.
              </span><a name="pone.0001826-Yang1" id="pone.0001826-Yang1"></a>Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, et al.  (2005) ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood  106: 584–592.  <ul class="find" data-citedArticleID="1077140" data-doi="10.1182/blood-2004-12-4942"><li><a href="http://dx.doi.org/10.1182/blood-2004-12-4942" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=ICAM-1+regulates+neutrophil+adhesion+and+transcellular+migration+of+TNF-alpha-activated+vascular+endothelium+under+flow." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22ICAM-1+regulates+neutrophil+adhesion+and+transcellular+migration+of+TNF-alpha-activated+vascular+endothelium+under+flow.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">53.
              </span><a name="pone.0001826-Roetger1" id="pone.0001826-Roetger1"></a>Roetger A, Merschjann A, Dittmar T, Jackisch C, Barnekow A, et al.  (1998) Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model. Am J Pathol  153: 1797–1806.  <ul class="find" data-citedArticleID="1077114" data-doi="10.1016/s0002-9440(10)65694-5"><li><a href="http://dx.doi.org/10.1016/s0002-9440(10)65694-5" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Selection+of+potentially+metastatic+subpopulations+expressing+c-erbB-2+from+breast+cancer+tissue+by+use+of+an+extravasation+model." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Selection+of+potentially+metastatic+subpopulations+expressing+c-erbB-2+from+breast+cancer+tissue+by+use+of+an+extravasation+model.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.XML" value="103493"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.PDF" value="386428"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g001.PNG_L" value="617302"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g001.PNG_M" value="21169"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g001.PNG_S" value="5597"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g001.TIF" value="1066368"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g001.PNG_I" value="7835"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g002.PNG_L" value="515202"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g002.PNG_M" value="205636"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g002.PNG_S" value="12857"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g002.TIF" value="771810"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g002.PNG_I" value="69376"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g003.PNG_L" value="922771"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g003.PNG_M" value="216622"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g003.PNG_S" value="16122"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g003.TIF" value="1458466"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g003.PNG_I" value="147255"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g004.PNG_L" value="648747"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g004.PNG_M" value="150026"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g004.PNG_S" value="10622"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g004.TIF" value="1037954"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g004.PNG_I" value="54823"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g005.PNG_L" value="623990"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g005.PNG_M" value="82415"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g005.PNG_S" value="8449"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g005.TIF" value="1382838"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g005.PNG_I" value="30570"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g006.PNG_L" value="706111"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g006.PNG_M" value="127661"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g006.PNG_S" value="10477"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g006.TIF" value="1276148"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001826.g006.PNG_I" value="46570"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001826&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001826" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001826&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001826&volume=&issue=&title=CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration&author_name=Ke%20Zen%2C%20Dan-Qing%20Liu%2C%20Ya-Lan%20Guo%2C%20Chen%20Wang%2C%20Jun%20Shan%2C%20Ming%20Fang%2C%20Chen-Yu%20Zhang%2C%20Yuan%20Liu&start_page=1&end_page=10" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001826" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001826" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001826" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001826&amp;t=CD44v4%20Is%20a%20Major%20E-Selectin%20Ligand%20that%20Mediates%20Breast%20Cancer%20Cell%20Transendothelial%20Migration" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001826&title=CD44v4%20Is%20a%20Major%20E-Selectin%20Ligand%20that%20Mediates%20Breast%20Cancer%20Cell%20Transendothelial%20Migration&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001826&amp;title=CD44v4%20Is%20a%20Major%20E-Selectin%20Ligand%20that%20Mediates%20Breast%20Cancer%20Cell%20Transendothelial%20Migration" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001826" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001826&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001826';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20CD44v4%20Is%20a%20Major%20E-Selectin%20Ligand%20that%20Mediates%20Breast%20Cancer%20Cell%20Transendothelial%20Migration http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001826" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001826" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">











          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Breast+cancer%22" title="Search for articles in the subject area:'Breast cancer'"><div class="flagText">Breast cancer</div></a>
              <div data-categoryid="18763" data-articleid="26476"
                   data-categoryname="Breast cancer"
                   class="flagImage" title="Flag 'Breast cancer' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cancer+cell+migration%22" title="Search for articles in the subject area:'Cancer cell migration'"><div class="flagText">Cancer cell migration</div></a>
              <div data-categoryid="33965" data-articleid="26476"
                   data-categoryname="Cancer cell migration"
                   class="flagImage" title="Flag 'Cancer cell migration' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cell+adhesion%22" title="Search for articles in the subject area:'Cell adhesion'"><div class="flagText">Cell adhesion</div></a>
              <div data-categoryid="20007" data-articleid="26476"
                   data-categoryname="Cell adhesion"
                   class="flagImage" title="Flag 'Cell adhesion' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cell+binding%22" title="Search for articles in the subject area:'Cell binding'"><div class="flagText">Cell binding</div></a>
              <div data-categoryid="19609" data-articleid="26476"
                   data-categoryname="Cell binding"
                   class="flagImage" title="Flag 'Cell binding' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Endothelial+cells%22" title="Search for articles in the subject area:'Endothelial cells'"><div class="flagText">Endothelial cells</div></a>
              <div data-categoryid="17407" data-articleid="26476"
                   data-categoryname="Endothelial cells"
                   class="flagImage" title="Flag 'Endothelial cells' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Metastasis%22" title="Search for articles in the subject area:'Metastasis'"><div class="flagText">Metastasis</div></a>
              <div data-categoryid="20021" data-articleid="26476"
                   data-categoryname="Metastasis"
                   class="flagImage" title="Flag 'Metastasis' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Recombinant+proteins%22" title="Search for articles in the subject area:'Recombinant proteins'"><div class="flagText">Recombinant proteins</div></a>
              <div data-categoryid="18471" data-articleid="26476"
                   data-categoryname="Recombinant proteins"
                   class="flagImage" title="Flag 'Recombinant proteins' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Small+interfering+RNA%22" title="Search for articles in the subject area:'Small interfering RNA'"><div class="flagText">Small interfering RNA</div></a>
              <div data-categoryid="19855" data-articleid="26476"
                   data-categoryname="Small interfering RNA"
                   class="flagImage" title="Flag 'Small interfering RNA' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=971'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=5046'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=5919&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>

<div class="block sidebar-comments">
    <div class="header">
        <h3>Comments</h3>
    </div>
      <p><a href="/annotation/listThread.action?root=9447">MDA-MB-435 Cell Line</a><br>Posted by PLoS_ONE_Group</p>
      <p><a href="/annotation/listThread.action?root=5637">Referee Comments: Referee 2</a><br>Posted by PLoS_ONE_Group</p>
</div>

</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
